syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	94.56849242888448
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.31953969	49.504049249401255
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6773226139999999	25.410536943522473
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5509259599999999	20.668621083018476
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.39011210088303
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.501790884	18.825262190057046
FRAXE INTELLECTUAL DISABILITY	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
LEBER CONGENITAL AMAUROSIS, TYPE II	0.5	18.75807511686187
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	18.75807511686187
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.4536205199999999	17.018095577419885
21Q22.11Q22.12 MICRODELETION SYNDROME	0.448165049	16.81342730778816
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43873091999999997	16.459495106899833
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.305074280664403
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	15.812955279585921
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.417133064	15.6492266964775
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.340027440062604
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.39775455000000004	14.922219453947182
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.39177305000000007	14.697816601324165
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.35371573	13.270052466711265
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.347552264	13.038822950294815
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346659854	13.005343162664737
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34249279	12.849010963607196
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
COG4-CDG	0.33463498399999997	12.55421633320374
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	12.5520908932284
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.32282005	12.110965494258211
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.30358739999999995	11.389430507465581
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.281718684	10.569000472590945
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.27791268399999997	10.426214004801391
TUBEROUS SCLEROSIS COMPLEX	0.2734533	10.258915084707528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26676428399999996	10.007968955535745
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.258465073	9.696614508838373
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.59025175850389
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.252332303	9.4665365881695
PALLISTER-HALL SYNDROME	0.250545554	9.399504644255545
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.23571430000000002	8.843093091037028
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.224265403	8.4135745511746
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22148379	8.30921913997452
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.217603494	8.163645372287204
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.211050643	7.917807629711997
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.697875089002378
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.198118319	7.4326366196568046
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.864528843860672
PHELAN-MCDERMID SYNDROME	0.182255733	6.837533460185442
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.178144109	6.683281156496858
UNILATERAL POLYMICROGYRIA	0.17616554	6.6090528646450695
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.172472984	6.470522379002632
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.169797403	6.370144880244136
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16954730999999998	6.360762353683731
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.169040973	6.34176653872284
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.168999303	6.340203240742599
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.16845374899999999	6.31973615491799
RETT SYNDROME, CONGENITAL VARIANT	0.167208419	6.273016167547428
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1658174	6.220830489765464
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.15850543460828
AICARDI SYNDROME; AIC	0.16326663000000002	6.125135419233789
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15849447399999997	5.9461024977990204
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.72728354897679
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852	5.563589555758885
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14639494400000003	5.492174712561575
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14540431399999998	5.4550100886555395
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.14145486999999998	5.306842154211862
AICARDI SYNDROME	0.14091214	5.2864810139955125
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.14026703999999998	5.262279345479737
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.13076913999999998	4.905954702174852
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.12808873299999998	4.805396150475327
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.128073749	4.804834008480226
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.126086973	4.730297821583469
DILATED CARDIOMYOPATHY WITH ATAXIA	0.125541419	4.709830735758859
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.125	4.689518779215468
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	4.620145940075378
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.536295843656997
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427328
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.116254733	4.361430028609441
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.114199733	4.2843343398791385
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.113443303	4.255955998357843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.112412984	4.217302395965183
DYSTONIA 16; DYT16	0.11111099999999999	4.168456968619278
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.168456968619278
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.107553644	4.03499866648844
SCHINZEL-GIEDION SYNDROME	0.10714290000000001	4.01958913287684
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10714290000000001	4.01958913287684
GITELMAN SYNDROME	0.1068426	4.008323032961652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.10628828400000001	3.9875272306286957
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10581362400000001	3.9697198147587565
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.104897414	3.9353471427531157
BILATERAL POLYMICROGYRIA	0.10466076400000002	3.9264689458003064
COG1-CDG	0.10141606	3.804740143072341
TRISOMY 8P	0.10089484900000001	3.785186312892872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.10067461400000001	3.7769239435461484
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
ADNP SYNDROME	0.09167751899999999	3.4393875758590626
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08971356	3.365707394962189
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08746936000000001	3.2815136506076668
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	3.2432794412584696
BECKWITH-WIEDEMANN SYNDROME	0.08532646	3.2011202922718196
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	3.2011202922718196
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07950794900000001	2.9828321594592455
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07947380999999999	2.981551395606416
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07883601000000001	2.9576235949873477
DDOST-CDG	0.078751519	2.95445381793795
ETHYLMALONIC ENCEPHALOPATHY	0.078751519	2.95445381793795
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07871398400000001	2.9530456492389274
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.952890519957711
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.078662284	2.951106064271843
TRICHOHEPATOENTERIC SYNDROME 1	0.0782101	2.934141861394558
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
DOORS SYNDROME	0.076953894	2.887013848374052
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.885858576043755
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.074751333	2.8043822389991115
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07413893999999999	2.78140761120903
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07366436	2.76360319663111
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.07288012399999999	2.734181681036415
MICROFORM HOLOPROSENCEPHALY	0.072851339	2.7331017786519376
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.07181257	2.6941311647898027
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07180266399999999	2.693759529805587
YOU-HOOVER-FONG SYNDROME; YHFS	0.06927438400000001	2.5989081974926687
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.069270249	2.598753068211452
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.06821447900000001	2.5591446422791937
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.549768230851279
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06795369999999999	2.549361218137393
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06795369999999999	2.549361218137393
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06795369999999999	2.549361218137393
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.5477979201571537
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.5294562743078863
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5215450186111994
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
AMISH INFANTILE EPILEPSY SYNDROME	0.06514384	2.443946088241662
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06384318	2.395150332278667
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06349773	2.3821903781804274
DISTAL MONOSOMY 12Q	0.06342171399999999	2.37933855050426
KABUKI SYNDROME	0.062653679	2.3505248340595024
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.060125484	2.255676690619353
MICROPHTHALMIA, SYNDROMIC 3	0.060125484	2.255676690619353
LATHOSTEROLOSIS	0.060121349000000004	2.255521561338137
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05904746	2.2152333802797934
NON-DISTAL MONOSOMY 20Q	0.058969589	2.2123119601449432
DIPHALLIA	0.0588235	2.2068312632734486
SPONDYLOCOSTAL DYSOSTOSIS 5	0.0588235	2.2068312632734486
ACRO-RENAL-MANDIBULAR SYNDROME	0.0588235	2.2068312632734486
PHAVER SYNDROME	0.0588235	2.2068312632734486
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.0588235	2.2068312632734486
ACRORENAL-MANDIBULAR SYNDROME	0.0588235	2.2068312632734486
ULNAR HEMIMELIA	0.0588235	2.2068312632734486
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05840336	2.191069227914252
WHITE-SUTTON SYNDROME; WHSUS	0.058102914000000006	2.179797650641131
WOLF-HIRSCHHORN SYNDROME	0.058062403	2.178277833879012
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.058038603999999994	2.1773849870196
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.057399979	2.1534262355765876
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05725402	2.147950415804624
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.05684260000000001	2.1325155212754656
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.1325155212754656
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.05684260000000001	2.1325155212754656
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05684260000000001	2.1325155212754656
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.056452209999999996	2.1178695913857215
HAMAMY SYNDROME; HMMS	0.056342399999999994	2.1137499429285564
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492718
3P25.3 MICRODELETION SYNDROME	0.0558768	2.096282423379735
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
CHROMOSOME 1P36 DELETION SYNDROME	0.055429073	2.0794854299840404
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.05542280399999999	2.079250241238225
PGM3-CDG	0.05539991899999999	2.078391684140126
CHRISTIANSON SYNDROME	0.05529573	2.074482913963425
PERLMAN SYNDROME	0.054823984	2.0567848201552668
FEMORAL-FACIAL SYNDROME	0.05454566	2.0463431751576158
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05352625	2.0080988364478554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.053467019000000005	2.005876717353362
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.052332303000000004	1.963306541424752
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037643999999994	1.9522520701130326
XQ12-Q13.3 DUPLICATION SYNDROME	0.051682389999999995	1.9389243076779015
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.051327884	1.9256246073231449
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
FOIX-CHAVANY-MARIE SYNDROME	0.051086973	1.9165865540541887
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	1.8981397504358157
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.05010186	1.8796289067489942
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.05	1.8758075116861874
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	1.8758075116861874
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	1.8758075116861874
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	1.8758075116861874
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	1.8758075116861874
ULBRIGHT-HODES SYNDROME	0.05	1.8758075116861874
ESOPHAGEAL ATRESIA	0.05	1.8758075116861874
HYPOPLASTIC LEFT HEART SYNDROME	0.05	1.8758075116861874
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	1.8758075116861874
CAUDAL REGRESSION SEQUENCE	0.05	1.8758075116861874
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.05	1.8758075116861874
PENILE AGENESIS	0.05	1.8758075116861874
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.048750749	1.8289404234905575
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.04795524899999999	1.7990963259796302
16P13.11 MICRODELETION SYNDROME	0.047386444	1.7777569521459373
8Q24.3 MICRODELETION SYNDROME	0.04717143299999999	1.7696905671680336
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.046979954000000004	1.762507012237431
LISSENCEPHALY, X-LINKED, 2	0.046963459000000006	1.7618881833393256
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04690249299999999	1.759600973724176
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7522953412407127
ZELLWEGER SYNDROME	0.046702509	1.7520983439358353
CRANIOLENTICULOSUTURAL DYSPLASIA	0.04608446	1.7289115248000326
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7241184614461718
MICROHYDRANENCEPHALY; MHAC	0.045729990000000005	1.7156131750266848
PYRIDOXINE-DEPENDENT EPILEPSY	0.045543283999999996	1.7086086846811466
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.045200840000000006	1.6957615041305096
TRISOMY 13	0.044985829000000005	1.6876951191526064
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.044616684000000004	1.6738462198745787
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.044419559000000004	1.6664508487597558
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.6618886973105835
XP22.13P22.2 DUPLICATION SYNDROME	0.044209878999999994	1.6585844623787482
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814	1.6461388922163631
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04371012999999999	1.639835803815595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.043289849000000005	1.6240684786792157
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6232024183510698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6225267524853604
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.04296454899999999	1.611864475008185
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04296454899999999	1.611864475008185
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04296454899999999	1.611864475008185
CRANIOLENTICULOSUTURAL DYSPLASIA	0.042784130000000004	1.6050958486991669
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042778383999999996	1.604880280899924
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	1.5915525184647925
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.042250359	1.5850708156727622
COG2-CDG	0.04221225399999999	1.5836412627681058
49,XXXYY SYNDROME	0.041666699999999994	1.5631741769434968
49,XYYYY SYNDROME	0.041666699999999994	1.5631741769434968
HISTIDINEMIA	0.041666699999999994	1.5631741769434968
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.5631741769434968
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5631741769434968
MERRF	0.041517359999999996	1.5575715150675926
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.04109376	1.5416796738285874
SARCOSINEMIA	0.041091234	1.541584908033097
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.5254614420825485
RUBINSTEIN-TAYBI SYNDROME	0.040125733000000004	1.5053630274662868
PHACE SYNDROME	0.040125733000000004	1.5053630274662868
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
FRONTOOCULAR SYNDROME	0.038827884	1.4566727294015984
STURGE-WEBER SYNDROME	0.038823749000000005	1.4565176001203821
PROTEUS SYNDROME	0.038823749000000005	1.4565176001203821
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
TRICHOTHIODYSTROPHY	0.038338984	1.4383310835523309
LISSENCEPHALY 2; LIS2	0.038338984	1.4383310835523309
CLAPO SYNDROME	0.038324	1.4377689415572286
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.038299149000000005	1.4368366277077707
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.038123973	1.4302646985744276
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03779343	1.417863997727722
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	1.411899305002062
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.037578419	1.4097976127498186
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.037578419	1.4097976127498186
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037578419	1.4097976127498186
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.037557703000000005	1.409020428181577
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037557703000000005	1.409020428181577
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.037557703	1.4090204281815768
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.037542719	1.408458286186475
SLC39A8-CDG	0.03750104900000001	1.4068949882062358
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.037147134	1.3936174598962672
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.037078529	1.3910436644094826
PULMONARY ARTERIAL HYPERTENSION	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
VON HIPPEL-LINDAU DISEASE	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
KASABACH-MERRITT SYNDROME	0.037037	1.3894856562064262
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.037037	1.3894856562064262
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03701214900000001	1.3885533423569683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03701214900000001	1.3885533423569683
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.037012149	1.388553342356968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036801273	1.3806420866602813
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.03658935399999999	1.3726917016189004
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356726
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	1.355159654291677
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.034801279000000004	1.3056100112897353
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03479043	1.3052029985758493
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.2918464987696392
MEIER-GORLIN SYNDROME 5; MGORS5	0.03430153	1.286861352726582
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034101503	1.2793571097437808
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.034090654	1.278950097029895
SANDHOFF DISEASE	0.034086518999999996	1.2787949677486787
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.034048984	1.277386799049656
OCULODENTODIGITAL DYSPLASIA	0.034044849	1.2772316697684396
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.034044849	1.2772316697684396
LEIGH SYNDROME	0.034044849	1.2772316697684396
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.034044848999999995	1.2772316697684394
SLC35A2-CDG	0.033560084	1.2590451532003883
PEHO SYNDROME	0.033560084	1.2590451532003883
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.2590451532003883
ATYPICAL RETT SYNDROME	0.033555949	1.258890023919172
ISOLATED CEREBELLAR AGENESIS	0.033555948999999995	1.2588900239191718
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555948999999995	1.2588900239191718
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.033545099999999994	1.2584830112052863
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033545099999999994	1.2584830112052863
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.2569197132250471
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	1.2569197132250471
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.250978768222485
TRANSALDOLASE DEFICIENCY	0.033274040000000005	1.2483138835229333
SECKEL SYNDROME	0.03301453	1.2385780673757796
ISOTRETINOIN-LIKE SYNDROME	0.03301453	1.2385780673757796
SECKEL SYNDROME 2; SCKL2	0.03301453	1.2385780673757796
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2306668116790926
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2306668116790926
NEURONAL CEROID LIPOFUSCINOSIS	0.032799519	1.2305116823978763
FLYNN-AIRD SYNDROME	0.032799519	1.2305116823978763
DEND SYNDROME	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
WIEDEMANN-STEINER SYNDROME	0.032611079	1.2234421390478334
POTOCKI-LUPSKI SYNDROME	0.032432993	1.2167610379173106
HUNTINGTON DISEASE	0.0322581	1.2101997258544839
DENT DISEASE	0.0322581	1.2101997258544839
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2101997258544839
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2101997258544839
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.2101997258544839
9P13 MICRODELETION SYNDROME	0.0322581	1.2101997258544839
LESCH-NYHAN SYNDROME	0.0322581	1.2101997258544839
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2101997258544839
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.2101997258544839
MILD CANAVAN DISEASE	0.0322581	1.2101997258544839
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
DIENCEPHALIC SYNDROME	0.0322581	1.2101997258544839
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.2101997258544839
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2101997258544839
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2101997258544839
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2101997258544839
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.031677013999999996	1.18839961617977
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.031462003	1.180333231201867
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.031462003	1.180333231201867
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.031040214	1.164509331710935
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.030797559000000002	1.1554058502759708
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467403	1.1430196681794056
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.030325114000000004	1.1376815326787992
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.030264433000000004	1.1354050151664667
BRAIN-LUNG-THYROID SYNDROME	0.029199683999999997	1.0954597317212593
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.029079784	1.090961545308236
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.02902313	1.0888361053328945
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.028806670000000003	1.0807153594533028
AL KAISSI SYNDROME; ALKAS	0.028767203000000005	1.0792347095520285
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	1.0704944594836272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.0704944594836272
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0632588696526497
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0632588696526497
TETRASOMY 9P	0.028292873	1.0614396740116663
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.027942763000000002	1.0483048946533373
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
MENINGIOMA	0.027777800000000002	1.0421161179623315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
DUBOWITZ SYNDROME	0.026947979	1.0109844286592327
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.026583284	0.9973024762497446
CORNELIA DE LANGE SYNDROME	0.026538449	0.9956204396540156
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02628886	0.9862568212333308
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.025813534	0.9684244196073357
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.025596763	0.9602920062050213
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.025544244	0.9583216955108963
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.025398863	0.9528675600737674
FONTAINE PROGEROID SYNDROME; FPS	0.0253958	0.9527526481056015
EMANUEL SYNDROME	0.025279093000000002	0.9483742507602743
7Q11.23 MICRODUPLICATION SYNDROME	0.025191309	0.9450809330281571
WIEDEMANN-STEINER SYNDROME; WDSTS	0.024795973000000002	0.9302494482593577
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.024749244000000004	0.9284963560750861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9277824237361381
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.024465430000000003	0.917848747412652
STÜVE-WIEDEMANN SYNDROME	0.024404799999999997	0.9155741432239812
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.024380713999999998	0.9146705292294517
TRANSKETOLASE DEFICIENCY	0.024101014	0.9041772620090793
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.023991389999999998	0.9000645915558573
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.023941729	0.8982015020191004
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.023928124000000002	0.8976910947951708
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.023654814	0.8874375557747916
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.023654814	0.8874375557747916
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.023634469999999998	0.8866743272144367
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02355546	0.8837101761844703
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023541763	0.8831963174747189
4Q21 MICRODELETION SYNDROME	0.023420059	0.8786304519266739
GABRIELE-DE VRIES SYNDROME	0.02335864	0.8763262474954687
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.023301949	0.8741994194225687
FG SYNDROME TYPE 1	0.023235663	0.8717126238881762
48,XXYY SYNDROME	0.023086663	0.8661227175033512
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02280507	0.8555584322105863
PITT-HOPKINS-LIKE SYNDROME	0.022631049	0.8490298342307636
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064703
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.022486643999999997	0.8436123145562625
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022293704	0.8363739485301679
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.8274391021905043
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.021990333000000004	0.8249926365176132
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.021843744	0.8194931815710016
DISTAL MONOSOMY 10Q	0.021826553	0.8188482414323337
HYPERPROLINEMIA, TYPE I	0.021430833	0.8040023504618444
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.021218083999999998	0.79602082701577
CRANIOFACIAL DYSSYNOSTOSIS	0.02115274	0.7935693716948975
SALT-AND-PEPPER SYNDROME	0.021125533999999998	0.7925487073116388
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021125533999999998	0.7925487073116388
X SMALL RINGS	0.021062034	0.7901664317717975
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.020998583999999997	0.7877860320394675
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.020965073000000004	0.7865288283289855
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.020903360000000003	0.7842135941496118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.020889414	0.783690393918452
PIERPONT SYNDROME	0.020830603	0.7814840316070566
C SYNDROME	0.020790309	0.7799723558495388
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
1Q44 MICRODELETION SYNDROME	0.020713033999999998	0.7770732953402278
EVEN-PLUS SYNDROME	0.020627794	0.7738754186943053
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.020579433	0.7720611001528521
LOEYS-DIETZ SYNDROME 5	0.020453029999999997	0.7673189462148586
CLASSICAL EHLERS-DANLOS SYNDROME	0.02030816	0.7618839815304992
HELSMOORTEL-VAN DER AA SYNDROME	0.020229323	0.7589263207945232
CORNELIA DE LANGE SYNDROME 1	0.020148419	0.7558911141760138
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.020073544000000002	0.7530820924272639
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.020016614	0.7509462979944579
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.019834649	0.7441196717171783
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.019719743	0.7398088409584223
BAKER-GORDON SYNDROME; BAGOS	0.019687904	0.7386143642511306
ADENYLOSUCCINASE DEFICIENCY	0.019543603	0.733200746256254
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.019294223000000003	0.723844968710968
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019237914000000002	0.7217324718074574
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.019174189	0.7193417551338133
CARDIOFACIOCUTANEOUS SYNDROME	0.019122814000000002	0.7174143629155557
TIMOTHY SYNDROME; TS	0.019093203	0.7163034721909848
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.01907494	0.7156183147392663
WRINKLY SKIN SYNDROME	0.019073984	0.7155824492996429
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.018941173000000002	0.710599891870952
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.018930733	0.7102082232625118
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.018930733	0.7102082232625118
COFFIN-SIRIS SYNDROME 1; CSS1	0.018889063	0.7086449252822725
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.018865103	0.7077460383226726
20Q13.33 MICRODELETION SYNDROME	0.018788549	0.7048740269576801
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.018537793	0.6954666271896723
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01830672	0.6867976578067151
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.018146659000000002	0.6807927852841552
TRANSIENT NEONATAL DIABETES MELLITUS	0.018134064	0.6803202693719612
PERMANENT NEONATAL DIABETES MELLITUS	0.018134064	0.6803202693719612
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018132633000000002	0.6802665837609769
INTELLECTUAL DISABILITY, WOLFF TYPE	0.018122729	0.6798950238090621
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.018006229999999998	0.6755244298229833
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.017893569999999998	0.671297860337652
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.017845203	0.6694833166992976
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.017836303	0.6691494229622176
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017836303	0.6691494229622176
ADENYLOSUCCINATE LYASE DEFICIENCY	0.017752719	0.666013673061082
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01774999	0.6659112914870942
CHROMOSOME 18Q DELETION SYNDROME	0.017748309	0.6658482268385512
GAUCHER DISEASE	0.01754684	0.6582898855671131
AYMÉ-GRIPP SYNDROME	0.017544484	0.6582014975171625
MONOSOMY 9P	0.017393643000000004	0.6525425238997575
SMITH-MAGENIS SYNDROME	0.017314633000000003	0.6495783728697909
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
TRISOMY 17P	0.017223014000000002	0.6461411807015274
PETERS PLUS SYNDROME	0.017102314	0.6416129813683168
KOOLEN-DE VRIES SYNDROME; KDVS	0.016875733000000004	0.6331125345322096
BOHRING-OPITZ SYNDROME	0.016875733000000004	0.6331125345322096
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.016848089000000004	0.6320754380751485
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.016798389	0.6302108854085324
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.016798389	0.6302108854085324
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.016773214	0.6292664163263983
DUPLICATION/INVERSION 15Q11	0.016769079000000003	0.6291112870451819
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.016757954	0.6286939198738317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016716283999999998	0.6271306218935924
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01670766	0.6268070826139769
YUNIS-VARON SYNDROME	0.0165672	0.621537564152148
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.016538454	0.6204591248975294
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.016534319	0.6203039956163129
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.016534319	0.6203039956163129
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.016496784	0.6188958269172902
JACOBSEN SYNDROME	0.016482793	0.6183709384593701
22Q11.2 MICRODUPLICATION SYNDROME	0.016440093	0.6167689988443901
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.016287584	0.6110474482883951
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016287584	0.6110474482883951
22Q11.2 DELETION SYNDROME	0.016280532999999996	0.610782921913097
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.016267203	0.6102828316304816
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.016267203	0.6102828316304816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.016228289	0.6088229281602865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.016214684	0.6083125209363567
EDINBURGH MALFORMATION SYNDROME	0.016133329000000002	0.6052603945340921
KLEEFSTRA SYNDROME	0.016069303	0.6028583854992277
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.016007884	0.6005541810680226
HARDIKAR SYNDROME	0.015992899999999997	0.5999920390729204
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.015973549	0.5992660640497477
TRISOMY 20P	0.01592103	0.5972957533556227
FLOATING-HARBOR SYNDROME	0.01592103	0.5972957533556227
14Q12 MICRODELETION SYNDROME	0.015894539	0.5963019130197811
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01589181	0.5961995314457933
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015792873	0.5924877960901193
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.015792873	0.5924877960901193
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.015750683999999997	0.5909050272279087
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.015742029999999997	0.5905803624637861
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01573666	0.590378900737031
20P13 MICRODELETION SYNDROME	0.015721649	0.5898157458058727
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5888156027567918
BARATELA-SCOTT SYNDROME	0.015606894000000001	0.5855105799858018
CEREBROFACIOTHORACIC DYSPLASIA	0.01555024	0.5833851400104604
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015531153999999998	0.5826691067670994
KLEEFSTRA SYNDROME	0.015523749	0.5823912996746187
2Q23.1 MICRODELETION SYNDROME	0.015523749	0.5823912996746187
CORNELIA DE LANGE SYNDROME 3	0.015510773	0.5819044901091859
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.015510773	0.5819044901091859
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5804106345230292
BARAITSER-WINTER SYNDROME 1; BRWS1	0.015359303000000001	0.5762219188332839
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015328613999999999	0.575070585698761
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.015328613999999999	0.575070585698761
CHROMOSOME 10Q26 DELETION SYNDROME	0.015317633	0.5746586208530445
SMITH-MAGENIS SYNDROME; SMS	0.015312873	0.574480043977932
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.015251454	0.5721758395467269
PSEUDOAMINOPTERIN SYNDROME	0.015251454	0.5721758395467269
ADAMS-OLIVER SYNDROME 5; AOS5	0.015247318999999999	0.5720207102655105
OCULOCEREBRORENAL SYNDROME OF LOWE	0.015223638999999999	0.5711323278279758
LATERAL MENINGOCELE SYNDROME	0.015221254	0.5710428518096684
AMISH LETHAL MICROCEPHALY	0.01520609	0.5704739569075243
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.015081684000000001	0.5658067227215476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.015047314000000001	0.5645172926380145
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.015043179	0.5643621633567981
16P13.2 MICRODELETION SYNDROME	0.015035202999999999	0.5640629345425339
CARTILAGE-HAIR HYPOPLASIA	0.01503233	0.5639551506429124
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01502503	0.5636812827462062
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.015000583999999999	0.5627641629375927
19P13.3 MICRODUPLICATION SYNDROME	0.015000583999999999	0.5627641629375927
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015000583999999999	0.5627641629375927
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01490692	0.5592502502421012
MEND SYNDROME	0.014873973	0.5580142056403506
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.014850464	0.5571322384645061
MONOSOMY 22Q13.3	0.014832303	0.5564509076601114
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014832303	0.5564509076601114
DESMOSTEROLOSIS	0.014783059999999999	0.5546034998741521
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0147059	0.5517087537221179
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0147059	0.5517087537221179
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0147059	0.5517087537221179
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.5517087537221179
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.5517087537221179
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.5517087537221179
TRICUSPID ATRESIA	0.0147059	0.5517087537221179
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0147059	0.5517087537221179
FIBROCHONDROGENESIS 1; FBCG1	0.0147059	0.5517087537221179
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0147059	0.5517087537221179
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.5517087537221179
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0147059	0.5517087537221179
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0147059	0.5517087537221179
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0147059	0.5517087537221179
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0146757	0.5505757659850595
RECOMBINANT CHROMOSOME 8 SYNDROME	0.014561203	0.5462802793317489
WILLIAMS SYNDROME	0.01450176	0.5440502068134057
DUBOWITZ SYNDROME	0.01450176	0.5440502068134057
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.5420956153862286
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5420956153862286
9Q33.3Q34.11 MICRODELETION SYNDROME	0.014447978999999998	0.5420325507376856
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0144238	0.5411254477411845
8P11.2 DELETION SYNDROME	0.014343403000000001	0.538109261810844
20Q11.2 MICRODUPLICATION SYNDROME	0.014343403000000001	0.538109261810844
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01430491	0.5366651526398971
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.01430491	0.5366651526398971
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.01430491	0.5366651526398971
DISTAL TRISOMY 6P	0.014290884	0.5361389511167188
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.014290884	0.5361389511167188
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.014272330000000001	0.5354428764652824
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
48,XXXY SYNDROME	0.014237102999999997	0.5341212950409989
49,XXXXY SYNDROME	0.014237102999999997	0.5341212950409989
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.014212203	0.5331871429001792
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014083284	0.5283505983281979
FUMARASE DEFICIENCY; FMRD	0.014083284	0.5283505983281979
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.014083284	0.5283505983281979
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.014083284	0.5283505983281979
DISTAL TRISOMY 17Q	0.014072303000000001	0.5279386334824814
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.014072303000000001	0.5279386334824814
PRIMARY PULMONARY HYPOPLASIA	0.013948229999999999	0.5232838921745325
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.013906559999999998	0.5217205941942932
TRISOMY 9P	0.013801984000000002	0.5177973052674514
DISTAL MONOSOMY 3P	0.013797849000000001	0.517642175986235
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.013748202999999999	0.5157796491917315
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.01374533	0.51567186529211
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01374533	0.51567186529211
HAND-FOOT-GENITAL SYNDROME	0.01374533	0.51567186529211
NETHERTON SYNDROME; NETH	0.013737353999999998	0.5153726364778457
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.013733218999999998	0.5152175071966293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
BARDET-BIEDL SYNDROME 1; BBS1	0.013695683999999998	0.5138093384976065
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01354018	0.5079754270716615
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.013526749000000001	0.5074715476578725
OGDEN SYNDROME; OGDNS	0.013451874	0.5046625259091224
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013337703	0.5003792695207878
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.013326853999999999	0.49997225680690216
8P INVERTED DUPLICATION/DELETION SYNDROME	0.013325169	0.49990904209375836
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013285183999999998	0.49840895882666286
3MC SYNDROME 1	0.013256430000000001	0.49733021944284245
BLOOM SYNDROME	0.013256430000000001	0.49733021944284245
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.013256430000000001	0.49733021944284245
1P36 DELETION SYNDROME	0.013225292999999999	0.49616207907301496
SECKEL SYNDROME 9; SCKL9	0.013206784	0.495467692648339
OCULO-PALATO-CEREBRAL SYNDROME	0.013206784	0.495467692648339
CYSTIC FIBROSIS	0.013191799999999998	0.4949055506532368
CASPASE 8 DEFICIENCY	0.013191799999999998	0.4949055506532368
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.013191799999999998	0.4949055506532368
IMMUNODEFICIENCY 58; IMD58	0.013191799999999998	0.4949055506532368
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01312523	0.4924081005321779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013105144	0.49165455113858336
AU-KLINE SYNDROME; AUKS	0.013045554000000001	0.4894189637461558
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.013045554000000001	0.4894189637461558
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.013045554000000001	0.4894189637461558
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.013045554000000001	0.4894189637461558
MILLER-DIEKER SYNDROME	0.013041419	0.48926383446493926
MECKEL SYNDROME, TYPE 10; MKS10	0.013041419	0.48926383446493926
ROIFMAN SYNDROME; RFMN	0.013005674000000002	0.48792281967483486
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012991772999999998	0.4874013076704357
ALSTRÖM SYNDROME	0.012991772999999998	0.4874013076704357
NETHERTON SYNDROME	0.012991772999999998	0.4874013076704357
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012991772999999998	0.4874013076704357
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.012985330000000002	0.48715959111448
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01290632	0.4841954400845135
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796284	0.48006731297739536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012796284	0.48006731297739536
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012796284	0.48006731297739536
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012796284	0.48006731297739536
RING CHROMOSOME 14 SYNDROME	0.012796284	0.48006731297739536
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012796284	0.48006731297739536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796284	0.48006731297739536
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.012781299999999999	0.4795051709822932
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.0127095	0.4768115113955119
XP22.3 MICRODELETION SYNDROME	0.0125	0.46895187792154686
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.0125	0.46895187792154686
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0125	0.46895187792154686
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0125	0.46895187792154686
ISOTRETINOIN SYNDROME	0.0125	0.46895187792154686
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0125	0.46895187792154686
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0125	0.46895187792154686
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0125	0.46895187792154686
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.012450353999999999	0.4670893511270433
48,XYYY SYNDROME	0.012450353999999999	0.4670893511270433
IMMUNODEFICIENCY 23; IMD23	0.012450353999999999	0.4670893511270433
ALSTROM SYNDROME; ALMS	0.012450353999999999	0.4670893511270433
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.012450353999999999	0.4670893511270433
47,XYY SYNDROME	0.012446218999999998	0.4669342218458268
MUCOPOLYSACCHARIDOSIS, TYPE II	0.012446218999999998	0.4669342218458268
BERNARD-SOULIER SYNDROME	0.012446218999999998	0.4669342218458268
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012347993	0.46324916047296916
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01233622	0.46280748283626755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.4596002271527865
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012233539	0.4589552870141185
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01221733	0.45834718773498007
11P15.4 MICRODUPLICATION SYNDROME	0.012210443	0.45808881400832047
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.012177862999999999	0.4568665378337057
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.012136193	0.4553032398534665
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.012125344	0.4548962271395808
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.012058973	0.45240624273241836
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609965
DUANE RETRACTION SYNDROME	0.012017303	0.450842944752179
XQ28 (MECP2) DUPLICATION	0.011979963	0.44944209170245175
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.011979963	0.44944209170245175
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.011979963	0.44944209170245175
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.011979963	0.44944209170245175
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011938292999999999	0.4478787937222125
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.011938292999999999	0.4478787937222125
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011938292999999999	0.4478787937222125
MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.4466222653024344
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	0.4466222653024344
YAO SYNDROME	0.011904799999999998	0.4466222653024344
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.4466222653024344
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	0.4466222653024344
AORTIC ARCH DEFECTS	0.011904799999999998	0.4466222653024344
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.4466222653024344
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.4466222653024344
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.4466222653024344
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.4466222653024344
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	0.4466222653024344
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.4466222653024344
PRIMARY CILIARY DYSKINESIA	0.011904799999999998	0.4466222653024344
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	0.4466222653024344
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	0.4466222653024344
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.4466222653024344
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.4466222653024344
MYOTONIA PERMANENS	0.011904799999999998	0.4466222653024344
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.4466222653024344
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.011904799999999998	0.4466222653024344
CHILBLAIN LUPUS	0.011904799999999998	0.4466222653024344
ICHTHYOSIS VULGARIS	0.011904799999999998	0.4466222653024344
CARCINOID SYNDROME	0.011904799999999998	0.4466222653024344
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.4466222653024344
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
DERMATITIS, ATOPIC	0.011904799999999998	0.4466222653024344
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	0.4466222653024344
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.4466222653024344
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.4466222653024344
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.4466222653024344
MICROTRIPLICATION 11Q24.1	0.0118799	0.4456881131616147
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.011848244	0.444500501909816
KBG SYNDROME	0.011765403	0.4413926265083041
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.011765403	0.4413926265083041
DIAMOND-BLACKFAN ANEMIA 1	0.01169212	0.43864333047072607
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.011664889	0.43762172818371153
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.011664889	0.43762172818371153
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.011636444	0.4365545812903132
FETAL ALCOHOL SYNDROME	0.011594774	0.43499128331007403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
COSTELLO SYNDROME; CSTLO	0.011481244	0.4307320747740393
ADAMS-OLIVER SYNDROME	0.011477109	0.4305769454928229
FETAL HYDANTOIN SYNDROME	0.011475884	0.43053098820878655
BRANCHIOOCULOFACIAL SYNDROME	0.011471749	0.4303758589275701
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.011434409	0.4289750058778429
RETT SYNDROME	0.011434409	0.4289750058778429
NORRIE DISEASE	0.011434409	0.4289750058778429
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.011396874	0.42756683717882005
19P13.13 MICRODELETION SYNDROME	0.011379763	0.4269248983321708
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.011237589	0.4215910771888413
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.011237589	0.4215910771888413
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.011181862999999998	0.4195004522009168
WAARDENBURG SYNDROME, TYPE 1; WS1	0.01112347	0.417309771640319
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.01112347	0.417309771640319
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.011091814	0.4161221603885203
DESANTO-SHINAWI SYNDROME	0.011008973	0.4130142849870084
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011008973	0.4130142849870084
PEDIATRIC-ONSET GRAVES DISEASE	0.010992344000000001	0.4123904289247718
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.010972	0.4116272003644169
GAUCHER DISEASE, PERINATAL LETHAL	0.010946539	0.410672001663316
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.010890863	0.4085832524829033
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010890863	0.4085832524829033
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.010890862999999999	0.40858325248290317
CRI-DU-CHAT SYNDROME	0.01085132	0.40709975135421117
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.010838344	0.4066129417887783
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010838344	0.4066129417887783
SMITH-KINGSMORE SYNDROME; SKS	0.010834209	0.40645781250756186
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.010834209	0.40645781250756186
INFANTILE SIALIC ACID STORAGE DISEASE	0.010777333	0.4043240439468686
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.010777333	0.4043240439468686
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010777333	0.4043240439468686
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.010777333	0.4043240439468686
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.010777333	0.4043240439468686
KBG SYNDROME	0.010771973	0.4041229573816159
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.010771973	0.4041229573816159
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.010735663	0.40276074596662925
MALAN OVERGROWTH SYNDROME	0.010715319	0.40199751740627443
NOONAN SYNDROME 7; NS7	0.010715319	0.40199751740627443
2Q37 MICRODELETION SYNDROME	0.010692963	0.4011588063516493
N-ACETYLASPARTATE DEFICIENCY; NACED	0.010692963	0.4011588063516493
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.010692963	0.4011588063516493
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010692963	0.4011588063516493
LOWE OCULOCEREBRORENAL SYNDROME	0.010677978999999999	0.40059666435654717
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.010640443999999999	0.39918849565752434
5Q14.3 MICRODELETION SYNDROME	0.010636308999999998	0.3990333663763079
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.010561244000000001	0.39621721655901354
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010537813	0.3953381756428871
GAUCHER DISEASE TYPE 3	0.01050459	0.39409177658367206
GAUCHER DISEASE TYPE 2	0.01050459	0.39409177658367206
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.010481158999999999	0.3932127356675456
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.010246763	0.38441910011736186
GALLOWAY-MOWAT SYNDROME	0.010246763	0.38441910011736186
CONGENITAL TOXOPLASMOSIS	0.010246763	0.38441910011736186
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010235914	0.38401208740347614
MONOSOMY 18P	0.010230554000000001	0.3838110008382234
SCARF SYNDROME	0.0101739	0.38168556086288197
MONOSOMY X	0.0101739	0.38168556086288197
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0101739	0.38168556086288197
NOONAN SYNDROME	0.0101739	0.38168556086288197
TURNER SYNDROME	0.0101739	0.38168556086288197
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0101739	0.38168556086288197
PELVISCAPULAR DYSPLASIA	0.0101739	0.38168556086288197
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0101739	0.38168556086288197
SCARF SYNDROME	0.0101739	0.38168556086288197
MOSAIC MONOSOMY X	0.0101739	0.38168556086288197
HOLMES-GANG SYNDROME	0.010151544	0.3808468498082569
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.010147409	0.38069172052704037
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.010147409	0.38069172052704037
CYSTINOSIS	0.01013656	0.3802847078131547
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.010134433	0.38020491096160763
MAN1B1-CDG	0.010134433	0.38020491096160763
SIALURIA	0.010134433	0.38020491096160763
PELGER-HUET ANOMALY; PHA	0.010120134	0.3796684675294156
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.010094889999999999	0.37872140983291547
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344046
PAINE SYNDROME	0.01001569	0.3757501307344046
RECOMBINANT 8 SYNDROME	0.010015543	0.3757446158603202
MENTAL RETARDATION, X-LINKED 91; MRX91	0.010015543	0.3757446158603202
HALL-RIGGS SYNDROME	0.009992259	0.37487108981827816
HENNEKAM-BEEMER SYNDROME	0.009992259	0.37487108981827816
KEPPEN-LUBINSKY SYNDROME	0.009992259	0.37487108981827816
ALAZAMI-YUAN SYNDROME	0.009978654	0.3743606825943484
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.009950589	0.37330779183803886
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.009950589	0.37330779183803886
COFFIN-LOWRY SYNDROME	0.009950589	0.37330779183803886
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.009950589	0.37330779183803886
NIEMANN-PICK DISEASE, TYPE C2	0.009936532999999999	0.37278046483035365
SHUKLA-VERNON SYNDROME; SHUVER	0.009936532999999999	0.37278046483035365
MENTAL RETARDATION, X-LINKED 72	0.009936532999999999	0.37278046483035365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009936532999999999	0.37278046483035365
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.009936532999999999	0.37278046483035365
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.009936532999999999	0.37278046483035365
MUCOPOLYSACCHARIDOSIS TYPE 2	0.009936532999999999	0.37278046483035365
BIOTINIDASE DEFICIENCY	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36783887503771784
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
KRABBE DISEASE	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
VERVERI-BRADY SYNDROME; VERBRAS	0.00980389	0.36780421011490183
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009781383	0.3669598341215914
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.009781383	0.3669598341215914
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009763643	0.3662942976164452
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.009752073	0.365860235758241
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.009752073	0.365860235758241
BOHRING-OPITZ SYNDROME	0.009752073	0.365860235758241
ROBERTS SYNDROME	0.009705344000000001	0.36410714357396934
PELIZAEUS-MERZBACHER DISEASE	0.009701209	0.3639520142927529
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.3635450015788672
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00969036	0.3635450015788672
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00969036	0.3635450015788672
PEMPHIGOID GESTATIONIS	0.00969036	0.3635450015788672
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00969036	0.3635450015788672
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.3635450015788672
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.3635450015788672
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00969036	0.3635450015788672
CRANIOFRONTONASAL DYSPLASIA	0.009685000000000001	0.36334391501361446
JUNG SYNDROME	0.009685000000000001	0.36334391501361446
POLAND SYNDROME	0.009685000000000001	0.36334391501361446
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.009685000000000001	0.36334391501361446
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.009685000000000001	0.36334391501361446
RING CHROMOSOME 6 SYNDROME	0.009685000000000001	0.36334391501361446
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.009685000000000001	0.36334391501361446
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.009631233999999999	0.361326821680148
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009593014	0.3598929544182151
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.009593014	0.3598929544182151
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009593014	0.3598929544182151
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.009593014	0.3598929544182151
AYME-GRIPP SYNDROME; AYGRP	0.009588879	0.3597378251369987
2P15P16.1 MICRODELETION SYNDROME	0.009581444	0.3594588925600109
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.009581444	0.3594588925600109
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35604075859606615
KAGAMI-OGATA SYNDROME	0.009490333	0.35604075859606615
KAGAMI-OGATA SYNDROME	0.009490333	0.35604075859606615
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.009474124	0.35543265931692775
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009474124	0.35543265931692775
CRANIOFRONTONASAL SYNDROME; CFNS	0.009474124	0.35543265931692775
OCULOSKELETODENTAL SYNDROME; OCSKD	0.009474124	0.35543265931692775
RITSCHER-SCHINZEL SYNDROME 1	0.009474124	0.35543265931692775
KAPUR-TORIELLO SYNDROME	0.009469989	0.3552775300357113
DISTAL MONOSOMY 10P	0.00940917	0.35299583529464645
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.009395114	0.3524685082869612
COFFIN-SIRIS SYNDROME 6; CSS6	0.009395114	0.3524685082869612
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.009395114	0.3524685082869612
HYDROXYKYNURENINURIA	0.009395114	0.3524685082869612
CHILDHOOD DISINTEGRATIVE DISORDER	0.009390978999999999	0.3523133790057447
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.009390978999999999	0.3523133790057447
AUTISM	0.009390978999999999	0.3523133790057447
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.009390978999999999	0.3523133790057447
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.009366432999999999	0.35139250758210777
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.009250813	0.34705489029208464
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009250813	0.34705489029208464
2Q24 MICRODELETION SYNDROME	0.009235829	0.34649274829698246
COG8-CDG	0.009235829	0.34649274829698246
CONO-SPONDYLAR DYSPLASIA	0.009235829	0.34649274829698246
ADRENOMYODYSTROPHY	0.009235829	0.34649274829698246
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.009222224000000001	0.34598234107305276
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009222224000000001	0.34598234107305276
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.009222224000000001	0.34598234107305276
ELSAHY-WATERS SYNDROME; ESWS	0.009222224000000001	0.34598234107305276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.009218089	0.3458272117918363
17Q24.2 MICRODELETION SYNDROME	0.009218089	0.3458272117918363
NEONATAL ADRENOLEUKODYSTROPHY	0.009194158999999999	0.3449294503167432
QAZI-MARKOUIZOS SYNDROME	0.009194158999999999	0.3449294503167432
1Q41Q42 MICRODELETION SYNDROME	0.009194158999999999	0.3449294503167432
GMS SYNDROME	0.009159790000000001	0.3436400577493604
DISTAL MONOSOMY 17Q	0.009159790000000001	0.3436400577493604
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.009159790000000001	0.3436400577493604
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.009159790000000001	0.3436400577493604
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009159790000000001	0.3436400577493604
SCHISIS ASSOCIATION	0.009159790000000001	0.3436400577493604
RENAL TUBULAR DYSGENESIS	0.009159790000000001	0.3436400577493604
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00904746	0.33942586859360624
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.00904746	0.33942586859360624
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00904746	0.33942586859360624
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00904746	0.33942586859360624
227320 FACIOTHORACOGENITAL SYNDROME	0.00904746	0.33942586859360624
HALLERMANN-STREIFF SYNDROME; HSS	0.00904401	0.33929643787529984
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.3357288020526737
VASCULAR EHLERS-DANLOS SYNDROME	0.008948914	0.3357288020526737
TYSHCHENKO SYNDROME	0.008948914	0.3357288020526737
CINCA SYNDROME	0.008948914	0.3357288020526737
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3355736727714572
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
SPONDYLOOCULAR SYNDROME; SOS	0.00892857	0.3349655734923188
HEART-HAND SYNDROME TYPE 2	0.00892857	0.3349655734923188
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00892857	0.3349655734923188
WILDERVANCK SYNDROME	0.00892857	0.3349655734923188
ISOLATED KLIPPEL-FEIL SYNDROME	0.00892857	0.3349655734923188
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00892857	0.3349655734923188
LEGIUS SYNDROME	0.00892857	0.3349655734923188
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00892857	0.3349655734923188
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.3349655734923188
PTERYGIUM COLLI, ISOLATED	0.00892857	0.3349655734923188
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00892857	0.3349655734923188
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.3349655734923188
THORACOMELIC DYSPLASIA	0.00892857	0.3349655734923188
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.3349655734923188
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.3349655734923188
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.3349655734923188
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.3349655734923188
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00892857	0.3349655734923188
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00892857	0.3349655734923188
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00892857	0.3349655734923188
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00892857	0.3349655734923188
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.3349655734923188
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00892857	0.3349655734923188
EMERY-NELSON SYNDROME	0.00892857	0.3349655734923188
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.3349655734923188
RING CHROMOSOME 8 SYNDROME	0.00892857	0.3349655734923188
SPONDYLO-OCULAR SYNDROME	0.00892857	0.3349655734923188
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00892857	0.3349655734923188
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.3349655734923188
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.008877532999999998	0.33305086173284015
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.008877532999999998	0.33305086173284015
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00884956	0.33200142246235226
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.00884956	0.33200142246235226
SMITH-MAGENIS SYNDROME	0.00884956	0.33200142246235226
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.00884956	0.33200142246235226
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.00884956	0.33200142246235226
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00884956	0.33200142246235226
PRIMARY DYSTONIA, DYT13 TYPE	0.00884956	0.33200142246235226
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.00884956	0.33200142246235226
WITTEVEEN-KOLK SYNDROME	0.008835863	0.33148756375260097
15Q24 MICRODELETION SYNDROME	0.008835863	0.33148756375260097
ACROCALLOSAL SYNDROME; ACLS	0.008820878999999998	0.33092542175749884
CROME SYNDROME	0.008705259	0.3265878044674757
LOWRY-MACLEAN SYNDROME	0.008705259	0.3265878044674757
HEREDITARY METHEMOGLOBINEMIA	0.008705259	0.3265878044674757
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.008705259	0.3265878044674757
COFS SYNDROME	0.008705259	0.3265878044674757
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.008705259	0.3265878044674757
DPM1-CDG	0.008705259	0.3265878044674757
TEMPLE-BARAITSER SYNDROME	0.008705259	0.3265878044674757
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.008705259	0.3265878044674757
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.008705259	0.3265878044674757
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.008705259	0.3265878044674757
SECKEL SYNDROME 7; SCKL7	0.008705259	0.3265878044674757
BOWEN-CONRADI SYNDROME	0.008705259	0.3265878044674757
MEHMO SYNDROME	0.008705259	0.3265878044674757
MUCOLIPIDOSIS TYPE II	0.00869441	0.32618079175359005
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.008676670000000001	0.3255152552484438
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.008676670000000001	0.3255152552484438
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.31867654877078894
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31867654877078894
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.31867654877078894
2Q31.1 MICRODELETION SYNDROME	0.008465073	0.31757695040743855
19P13.12 MICRODELETION SYNDROME	0.008465073	0.31757695040743855
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008465073	0.31757695040743855
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
FATCO SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31526171622806476
NEMALINE MYOPATHY 10	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
SILVER-RUSSELL SYNDROME	0.00840336	0.31526171622806476
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31526171622806476
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31526171622806476
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.31526171622806476
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.31526171622806476
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
VACTERL/VATER ASSOCIATION	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
HYDROLETHALUS	0.00840336	0.31526171622806476
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.31304353632934556
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008344233999999999	0.31304353632934556
TOLUENE EMBRYOPATHY	0.008294444	0.31117560720920845
MONOSOMY 5P	0.00816384	0.30627584792408324
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.30627584792408324
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.30627584792408324
RING CHROMOSOME 7 SYNDROME	0.00816384	0.30627584792408324
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.30627584792408324
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008121103	0.30467252021154456
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.007965324	0.29882829184428533
17Q21.31 MICRODUPLICATION SYNDROME	0.007965324	0.29882829184428533
12Q14 MICRODELETION SYNDROME	0.007965324	0.29882829184428533
300270 ADRENOMYODYSTROPHY	0.007952964	0.29836459222739653
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29836459222739653
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29836459222739653
LISSENCEPHALY 5; LIS5	0.007948829	0.29820946294618
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29820946294618
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29820946294618
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.007948829	0.29820946294618
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29820946294618
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.007948829	0.29820946294618
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.29820946294618
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.29820946294618
FRYNS SYNDROME	0.007948829	0.29820946294618
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007948829	0.29820946294618
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.29820946294618
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29820946294618
FETAL TRIMETHADIONE SYNDROME	0.007923654	0.2972649938640461
BRANCHIOSKELETOGENITAL SYNDROME	0.007919519	0.2971098645828296
MELAS	0.00779868	0.2925764505047367
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.2925764505047367
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00779868	0.2925764505047367
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00779868	0.2925764505047367
OLIVER SYNDROME	0.00779868	0.2925764505047367
MEIER-GORLIN SYNDROME 2; MGORS2	0.007790559999999999	0.2922718193648388
TRISOMY 4P	0.00774889	0.2907085213845995
DISTAL MONOSOMY 15Q	0.007676063	0.28797633271152817
15Q14 MICRODELETION SYNDROME	0.007590533	0.28476757638203776
MULTIPLE SULFATASE DEFICIENCY	0.007590533	0.28476757638203776
GLASS SYNDROME	0.007590533	0.28476757638203776
DISTAL MONOSOMY 1Q	0.007590533	0.28476757638203776
WIEACKER-WOLFF SYNDROME	0.007590533	0.28476757638203776
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28466519480804997
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.007575548999999999	0.28420543438693563
DISTAL MONOSOMY 6P	0.007538014	0.28279726568791286
MOMO SYNDROME	0.007533879	0.2826421364066964
15Q OVERGROWTH SYNDROME	0.007533879	0.2826421364066964
16Q24.3 MICRODELETION SYNDROME	0.007533879	0.2826421364066964
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.007533879	0.2826421364066964
TRISOMY XQ28	0.00740741	0.2778975064027876
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2778975064027876
KID SYNDROME	0.00740741	0.2778975064027876
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2778975064027876
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.2778975064027876
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2778975064027876
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.2778975064027876
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2778975064027876
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2778975064027876
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2778975064027876
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.007219743000000001	0.2708569630368754
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007219743000000001	0.2708569630368754
HOLOPROSENCEPHALY	0.007219743	0.27085696303687534
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007167224000000001	0.26888665234275044
GERMAN SYNDROME	0.007167224000000001	0.26888665234275044
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.007163089	0.268731523061534
MENTAL RETARDATION, X-LINKED 21	0.007163089	0.268731523061534
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0070491139999999996	0.2644556198386453
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0070491139999999996	0.2644556198386453
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0070491139999999996	0.2644556198386453
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
FACIOCARDIORENAL SYNDROME	0.0070341299999999995	0.26389347784354317
PSEUDODIASTROPHIC DYSPLASIA	0.0070341299999999995	0.26389347784354317
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00699246	0.2623301798633039
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00699246	0.2623301798633039
ZTTK SYNDROME; ZTTKS	0.006919633	0.2595979911902325
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.006834102999999999	0.2563892348607421
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.006834102999999999	0.2563892348607421
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006834102999999999	0.2563892348607421
HOLOPROSENCEPHALY 11	0.006678324	0.2505450064934829
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.2505450064934829
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.2505450064934829
DESBUQUOIS DYSPLASIA 2; DBQD2	0.006678324	0.2505450064934829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0066741890000000005	0.25038987721226647
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.0066741890000000005	0.25038987721226647
MARSHALL-SMITH SYNDROME; MRSHSS	0.00666334	0.24998286449838075
ACROOSTEOLYSIS DOMINANT TYPE	0.00666334	0.24998286449838075
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.0066216700000000005	0.2484195665181415
NON-DISTAL MONOSOMY 10Q	0.0066216700000000005	0.2484195665181415
GASTROCUTANEOUS SYNDROME	0.0066216700000000005	0.2484195665181415
MCDONOUGH SYNDROME	0.0066216700000000005	0.2484195665181415
MCDONOUGH SYNDROME	0.0066216700000000005	0.2484195665181415
WAARDENBURG SYNDROME TYPE 1	0.0066216700000000005	0.2484195665181415
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0066216700000000005	0.2484195665181415
MENTAL RETARDATION, BUENOS AIRES TYPE	0.006589090000000001	0.24719729034352678
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.006503559999999999	0.24398853401403636
TEEBI-SHALTOUT SYNDROME; TBSH	0.006503559999999999	0.24398853401403636
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.006503559999999999	0.24398853401403636
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.006463313	0.24247862151557972
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006463313	0.24247862151557972
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.006430732999999999	0.24125634534096496
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006389063	0.23969304736072575
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.006389063	0.23969304736072575
MYHRE SYNDROME	0.006389063	0.23969304736072575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006389063	0.23969304736072575
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.006389063	0.23969304736072575
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.006292684	0.23607727831734968
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006292684	0.23607727831734968
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.006292684	0.23607727831734968
MENTAL RETARDATION, X-LINKED 107; MRX107	0.006292684	0.23607727831734968
OHDO SYNDROME	0.006288548999999999	0.23592214903613318
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006288548999999999	0.23592214903613318
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.006288548999999999	0.23592214903613318
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.006288548999999999	0.23592214903613318
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.006288548999999999	0.23592214903613318
9Q SUBTELOMERIC DELETION SYNDROME	0.00613277	0.23007792066887398
MONOSOMY 22	0.00613277	0.23007792066887398
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.23007792066887398
NON-DISTAL TRISOMY 13Q	0.00613277	0.23007792066887398
PIEBALDISM	0.00613277	0.23007792066887398
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00613277	0.23007792066887398
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.23007792066887398
XYLT1-CDG	0.00613277	0.23007792066887398
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.22216666497218723
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0059218940000000005	0.22216666497218723
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0059218940000000005	0.22216666497218723
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0059218940000000005	0.22216666497218723
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.005917759	0.2220115356909708
ZIMMERMANN-LABAND SYNDROME 1	0.005917759	0.2220115356909708
17Q12 MICRODUPLICATION SYNDROME	0.005917759	0.2220115356909708
EPILEPSY-TELANGIECTASIA	0.005917759	0.2220115356909708
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005917759	0.2220115356909708
ZLOTOGORA-OGUR SYNDROME	0.005917759	0.2220115356909708
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.005917759	0.2220115356909708
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005917759	0.2220115356909708
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.005917759	0.2220115356909708
FOUNTAIN SYNDROME	0.005917759	0.2220115356909708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.005917759	0.2220115356909708
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005917759	0.2220115356909708
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.005917759	0.2220115356909708
TURNPENNY-FRY SYNDROME; TPFS	0.005889314	0.22094438879757247
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.005847644000000001	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005847644000000001	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.005847644000000001	0.21938109081733326
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.005847644000000001	0.21938109081733326
RENPENNING SYNDROME 1; RENS1	0.005843509	0.21922596153611681
LATERAL MENINGOCELE SYNDROME	0.00574713	0.21561019249274074
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00574713	0.21561019249274074
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00574713	0.21561019249274074
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00574713	0.21561019249274074
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00574713	0.21561019249274074
CRANIOECTODERMAL DYSPLASIA 4	0.00574713	0.21561019249274074
AREDYLD SYNDROME	0.00574713	0.21561019249274074
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.00574713	0.21561019249274074
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.005674303	0.21287800381966934
PMM2-CDG	0.005674303	0.21287800381966934
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005632633	0.21131470583943007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.005632633	0.21131470583943007
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.005632633	0.21131470583943007
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005632633	0.21131470583943007
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.2016995791475783
WAARDENBURG-SHAH SYNDROME	0.00537634	0.2016995791475783
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.2016995791475783
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.2016995791475783
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.2016995791475783
LICHTENSTEIN SYNDROME	0.00537634	0.2016995791475783
SOMATOMAMMOTROPINOMA	0.00537634	0.2016995791475783
ISOLATED TRIGONOCEPHALY	0.00537634	0.2016995791475783
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.2016995791475783
WAARDENBURG SYNDROME	0.00537634	0.2016995791475783
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.2016995791475783
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00537634	0.2016995791475783
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.2016995791475783
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.2016995791475783
ACROMEGALY	0.00537634	0.2016995791475783
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.2016995791475783
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.2016995791475783
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.2016995791475783
PRIMROSE SYNDROME; PRIMS	0.00537634	0.2016995791475783
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.2016995791475783
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00537634	0.2016995791475783
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005302090000000001	0.19891400499272432
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.005302090000000001	0.19891400499272432
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005143733000000001	0.19297305999016257
PETERS-PLUS SYNDROME; PTRPLS	0.005143733	0.19297305999016254
COFFIN-SIRIS SYNDROME 5	0.005143732999999999	0.1929730599901625
CHROMOSOME 1P35 DELETION SYNDROME	0.005143732999999999	0.1929730599901625
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005132884	0.19256604727627685
POPOV-CHANG SYNDROME; POPCHAS	0.005132884	0.19256604727627685
COFFIN-SIRIS SYNDROME 8; CSS8	0.005128749	0.1924109179950604
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.005091214	0.1910027492960376
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.005091214	0.1910027492960376
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.005091214	0.1910027492960376
2Q23.1 MICRODUPLICATION SYNDROME	0.005091214	0.1910027492960376
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.005091214	0.1910027492960376
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.005091214	0.1910027492960376
COFFIN-SIRIS SYNDROME 7; CSS7	0.005091214	0.1910027492960376
PALLISTER-KILLIAN SYNDROME	0.0050870789999999996	0.1908476200148211
AL-RAQAD SYNDROME; ARS	0.004602314000000001	0.17266110344677008
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.004602314000000001	0.17266110344677008
%300712 CRANIOFACIOSKELETAL SYNDROME	0.004602314	0.17266110344677005
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004598179000000001	0.17250597416555363
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.004598179000000001	0.17250597416555363
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.004598179000000001	0.17250597416555363
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004598179000000001	0.17250597416555363
13Q12.3 MICRODELETION SYNDROME	0.004587330000000001	0.17209896145166795
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00454566	0.17053566347142868
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00454566	0.17053566347142868
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00454566	0.17053566347142868
TETRASOMY 12P	0.00454566	0.17053566347142868
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00454566	0.17053566347142868
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004387303	0.1645947184688669
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004387303	0.1645947184688669
WILSON-TURNER SYNDROME	0.004387303	0.1645947184688669
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004387303	0.1645947184688669
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004387303	0.1645947184688669
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004387303	0.1645947184688669
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.004387303	0.1645947184688669
PRADER-WILLI SYNDROME; PWS	0.004387303	0.1645947184688669
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004375733	0.16416065661066268
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.004375733	0.16416065661066268
MONOSOMY 18Q	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004375733	0.16416065661066268
SSR4-CDG	0.004375733	0.16416065661066268
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004375733	0.16416065661066268
ALG11-CDG	0.004375733	0.16416065661066268
C SYNDROME	0.004375733	0.16416065661066268
PITT-HOPKINS SYNDROME	0.004375733	0.16416065661066268
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004375733	0.16416065661066268
1Q21.1 MICRODELETION SYNDROME	0.004375733	0.16416065661066268
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004375733	0.16416065661066268
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00405676	0.15219401762216114
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00405676	0.15219401762216114
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00405676	0.15219401762216114
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00405676	0.15219401762216114
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00405676	0.15219401762216114
ROIFMAN SYNDROME	0.00405676	0.15219401762216114
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003845884	0.1442827619254744
CHROMOSOME 9P DELETION SYNDROME	0.003845884	0.1442827619254744
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003845884	0.1442827619254744
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.003845884	0.1442827619254744
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.003845884	0.1442827619254744
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.003845884	0.1442827619254744
AICA-RIBOSIDURIA	0.003841749	0.14412763264425796
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.003841749	0.14412763264425796
BARAITSER-WINTER SYNDROME 2; BRWS2	0.003841749	0.14412763264425796
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.003841749	0.14412763264425796
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.003841749	0.14412763264425796
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.003841749	0.14412763264425796
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.003841749	0.14412763264425796
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.003841749	0.14412763264425796
HADZISELIMOVIC SYNDROME	0.003834314	0.1438487000672702
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.003834314	0.1438487000672702
MARINESCO-SJOGREN SYNDROME; MSS	0.003834314	0.1438487000672702
ISOLATED COMPLEX I DEFICIENCY	0.003834314	0.1438487000672702
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.003834314	0.1438487000672702
XERODERMA PIGMENTOSUM	0.003830179	0.14369357078605377
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.003830179	0.14369357078605377
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.003830179	0.14369357078605377
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.003619303	0.13578231508936703
LEIGH SYNDROME; LS	0.003619303	0.13578231508936703
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.003619303	0.13578231508936703
GAUCHER DISEASE, TYPE II	0.003619303	0.13578231508936703
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.003619303	0.13578231508936703
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.003619303	0.13578231508936703
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003619303	0.13578231508936703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003619303	0.13578231508936703
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.003619303	0.13578231508936703
6Q TERMINAL DELETION SYNDROME	0.003619303	0.13578231508936703
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.003619303	0.13578231508936703
PONTINE TEGMENTAL CAP DYSPLASIA	0.003619303	0.13578231508936703
CONGENITAL DISORDER OF GLYCOSYLATION	0.003619303	0.13578231508936703
1Q21.1 MICRODUPLICATION SYNDROME	0.003619303	0.13578231508936703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.003619303	0.13578231508936703
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.003619303	0.13578231508936703
2Q37 MONOSOMY	0.00330033	0.1238156761008655
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00330033	0.1238156761008655
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00330033	0.1238156761008655
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00330033	0.1238156761008655
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00330033	0.1238156761008655
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00330033	0.1238156761008655
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00330033	0.1238156761008655
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00330033	0.1238156761008655
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00330033	0.1238156761008655
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00330033	0.1238156761008655
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00330033	0.1238156761008655
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00330033	0.1238156761008655
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00330033	0.1238156761008655
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00330033	0.1238156761008655
3Q27.3 MICRODELETION SYNDROME	0.00330033	0.1238156761008655
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00330033	0.1238156761008655
ATELOSTEOGENESIS TYPE II	0.00330033	0.1238156761008655
HUNTER-MACDONALD SYNDROME	0.00330033	0.1238156761008655
CHROMOSOME 13Q14 DELETION SYNDROME	0.00330033	0.1238156761008655
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00330033	0.1238156761008655
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00330033	0.1238156761008655
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00330033	0.1238156761008655
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00330033	0.1238156761008655
MEIER-GORLIN SYNDROME 6; MGORS6	0.00328876	0.12338161424266131
SHPRINTZEN-GOLDBERG SYNDROME	0.00328876	0.12338161424266131
JOHANSON-BLIZZARD SYNDROME; JBS	0.00328876	0.12338161424266131
MEIER-GORLIN SYNDROME 1; MGORS1	0.00328876	0.12338161424266131
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00328876	0.12338161424266131
JACOBSEN SYNDROME	0.00328876	0.12338161424266131
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.003130403	0.11744066924009951
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.003130403	0.11744066924009951
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003130403	0.11744066924009951
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.003130403	0.11744066924009951
JABERI-ELAHI SYNDROME; JABELS	0.003130403	0.11744066924009951
VICI SYNDROME; VICIS	0.003130403	0.11744066924009951
RFT1-CDG	0.003130403	0.11744066924009951
6Q25 MICRODELETION SYNDROME	0.003130403	0.11744066924009951
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.003130403	0.11744066924009951
10Q22.3Q23.3 MICRODELETION SYNDROME	0.003130403	0.11744066924009951
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.003130403	0.11744066924009951
LATHOSTEROLOSIS	0.003130403	0.11744066924009951
PELIZAEUS-MERZBACHER DISEASE	0.003130403	0.11744066924009951
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003130403	0.11744066924009951
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003130403	0.11744066924009951
STT3A-CDG	0.0031304029999999995	0.11744066924009948
STT3B-CDG	0.0031304029999999995	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0031304029999999995	0.11744066924009948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0031304029999999995	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0031304029999999995	0.11744066924009948
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.0031304029999999995	0.11744066924009948
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.0031304029999999995	0.11744066924009948
INFANTILE LIVER FAILURE SYNDROME 1	0.0031304029999999995	0.11744066924009948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0031304029999999995	0.11744066924009948
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0031304029999999995	0.11744066924009948
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0031304029999999995	0.11744066924009948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0031304029999999995	0.11744066924009948
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0031304029999999995	0.11744066924009948
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.0031304029999999995	0.11744066924009948
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.003088733	0.11587737125986024
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003088733	0.11587737125986024
MEHMO SYNDROME; MEHMO	0.003088733	0.11587737125986024
ADAMS-OLIVER SYNDROME 2; AOS2	0.003088733	0.11587737125986024
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003088733	0.11587737125986024
MATERNAL PHENYLKETONURIA	0.003088733	0.11587737125986024
COFFIN-SIRIS SYNDROME	0.003088733	0.11587737125986024
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.003088733	0.11587737125986024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003088733	0.11587737125986024
8P23.1 MICRODELETION SYNDROME	0.003088733	0.11587737125986024
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.003088733	0.11587737125986024
CK SYNDROME	0.003088733	0.11587737125986024
CHROMOSOME 19P13.13 DELETION SYNDROME	0.003088733	0.11587737125986024
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.003088733	0.11587737125986024
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.003088733	0.11587737125986024
KOOLEN-DE VRIES SYNDROME	0.003088733	0.11587737125986024
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.003088733	0.11587737125986024
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.003088733	0.11587737125986024
COHEN SYNDROME	0.003088733	0.11587737125986024
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003088733	0.11587737125986024
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.003088733	0.11587737125986024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.003088733	0.11587737125986024
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.003088733	0.11587737125986024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003088733	0.11587737125986024
EMANUEL SYNDROME	0.003088733	0.11587737125986024
KABUKI SYNDROME 1	0.003088733	0.11587737125986024
15Q13.3 MICRODELETION SYNDROME	0.003088733	0.11587737125986024
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0030887329999999998	0.11587737125986022
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0030887329999999998	0.11587737125986022
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0030887329999999998	0.11587737125986022
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0030887329999999998	0.11587737125986022
SMITH-LEMLI-OPITZ SYNDROME	0.0030887329999999998	0.11587737125986022
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0030778840000000003	0.11547035854597458
TREACHER-COLLINS SYNDROME	0.003077884	0.11547035854597458
AARSKOG-SCOTT SYNDROME	0.003077884	0.11547035854597458
PRADER-WILLI SYNDROME	0.003073749	0.11531522926475812
ATAXIA-TELANGIECTASIA	0.003073749	0.11531522926475812
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0030737489999999998	0.11531522926475811
HADDAD SYNDROME	0.0030737489999999998	0.11531522926475811
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.002588984	0.09712871269670703
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002588984	0.09712871269670703
EAR-PATELLA-SHORT STATURE SYNDROME	0.002588984	0.09712871269670703
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002588984	0.09712871269670703
OROFACIODIGITAL SYNDROME TYPE 4	0.002588984	0.09712871269670703
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.002588984	0.09712871269670703
3Q29 MICRODELETION SYNDROME	0.002588984	0.09712871269670703
LIG4 SYNDROME	0.002588984	0.09712871269670703
17P11.2 MICRODUPLICATION SYNDROME	0.002588984	0.09712871269670703
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.002588984	0.09712871269670703
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002588984	0.09712871269670703
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002588984	0.09712871269670703
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002588984	0.09712871269670703
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.002588984	0.09712871269670703
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.002588984	0.09712871269670703
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002588984	0.09712871269670703
MARDEN-WALKER SYNDROME	0.002588984	0.09712871269670703
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.002588984	0.09712871269670703
HOYERAAL-HREIDARSSON SYNDROME	0.002588984	0.09712871269670703
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002588984	0.09712871269670703
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.002588984	0.09712871269670703
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.002588984	0.09712871269670703
MEVALONIC ACIDURIA; MEVA	0.002588984	0.09712871269670703
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.002588984	0.09712871269670703
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002588984	0.09712871269670703
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0025848489999999997	0.09697358341549057
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0025848489999999997	0.09697358341549057
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0025848489999999997	0.09697358341549057
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0025848489999999997	0.09697358341549057
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0025848489999999997	0.09697358341549057
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0025848489999999997	0.09697358341549057
SYMMETRICAL THALAMIC CALCIFICATIONS	0.0025848489999999997	0.09697358341549057
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0025848489999999997	0.09697358341549057
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0025848489999999997	0.09697358341549057
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0025848489999999997	0.09697358341549057
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0025848489999999997	0.09697358341549057
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0025848489999999997	0.09697358341549057
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0025848489999999997	0.09697358341549057
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0025848489999999997	0.09697358341549057
HARROD SYNDROME	0.0025848489999999997	0.09697358341549057
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0025848489999999997	0.09697358341549057
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0025848489999999997	0.09697358341549057
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0025848489999999997	0.09697358341549057
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0025848489999999997	0.09697358341549057
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.002547314	0.09556541471646778
OPTIC ATROPHY 11; OPA11	0.002547314	0.09556541471646778
2Q32Q33 MICRODELETION SYNDROME	0.002547314	0.09556541471646778
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002547314	0.09556541471646778
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.002547314	0.09556541471646778
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.002547314	0.09556541471646778
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.002547314	0.09556541471646778
FANCONI ANEMIA	0.002547314	0.09556541471646778
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.002547314	0.09556541471646778
MIETENS SYNDROME	0.002547314	0.09556541471646778
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002547314	0.09556541471646778
CRANIOSYNOSTOSIS 6; CRS6	0.002547314	0.09556541471646778
ROTHMUND-THOMSON SYNDROME	0.002547314	0.09556541471646778
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002547314	0.09556541471646778
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.002547314	0.09556541471646778
OROFACIODIGITAL SYNDROME IX; OFD9	0.002547314	0.09556541471646778
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002547314	0.09556541471646778
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002547314	0.09556541471646778
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002547314	0.09556541471646778
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.002547314	0.09556541471646778
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.002547314	0.09556541471646778
CHARGE SYNDROME	0.002547314	0.09556541471646778
MARINESCO-SJÖGREN SYNDROME	0.002547314	0.09556541471646778
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.002547314	0.09556541471646778
6Q16 MICRODELETION SYNDROME	0.002547314	0.09556541471646778
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.002547314	0.09556541471646778
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.002547314	0.09556541471646778
PENTASOMY X	0.002547314	0.09556541471646778
MUCOLIPIDOSIS IV; ML4	0.002547314	0.09556541471646778
SECKEL SYNDROME 1; SCKL1	0.002543179	0.09541028543525132
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.002543179	0.09541028543525132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002543179	0.09541028543525132
COCKAYNE SYNDROME	0.002543179	0.09541028543525132
PITT-HOPKINS SYNDROME	0.002543179	0.09541028543525132
MOWAT-WILSON SYNDROME; MOWS	0.002543179	0.09541028543525132
INCONTINENTIA PIGMENTI; IP	0.002543179	0.09541028543525132
RENPENNING SYNDROME	0.002543179	0.09541028543525132
CYCLIC VOMITING SYNDROME	0.002543179	0.09541028543525132
CONGENITAL RUBELLA SYNDROME	0.002543179	0.09541028543525132
ANGELMAN SYNDROME	0.002543179	0.09541028543525132
PRIMARY CUTIS VERTICIS GYRATA	0.002543179	0.09541028543525132
MOWAT-WILSON SYNDROME	0.002543179	0.09541028543525132
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002543179	0.09541028543525132
DISTAL MONOSOMY 7Q36	0.002543179	0.09541028543525132
MARDEN-WALKER SYNDROME	0.002543179	0.09541028543525132
COG5-CDG	0.002543179	0.09541028543525132
COCKAYNE SYNDROME A; CSA	0.002543179	0.09541028543525132
TOWNES-BROCKS SYNDROME	0.00253233	0.09500327272136566
MULTIMINICORE MYOPATHY	0.00253233	0.09500327272136566
ALAGILLE SYNDROME	0.00253233	0.09500327272136566
MELNICK-NEEDLES SYNDROME	0.00253233	0.09500327272136566
FREEMAN-SHELDON SYNDROME	0.00253233	0.09500327272136566
ALAGILLE SYNDROME 1; ALGS1	0.00253233	0.09500327272136566
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00253233	0.09500327272136566
ELLIS VAN CREVELD SYNDROME	0.00253233	0.09500327272136566
16P12.1P12.3 TRIPLICATION SYNDROME	0.00253233	0.09500327272136566
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00253233	0.09500327272136566
PROGEROID SYNDROME, PETTY TYPE	0.00253233	0.09500327272136566
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0023739729999999997	0.08906232771880385
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0023739729999999997	0.08906232771880385
TARP SYNDROME	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0023739729999999997	0.08906232771880385
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0023739729999999997	0.08906232771880385
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0023739729999999997	0.08906232771880385
CITRULLINEMIA, CLASSIC	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880385
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0023739729999999997	0.08906232771880385
PRADER-WILLI-LIKE SYNDROME	0.0023739729999999997	0.08906232771880385
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0023739729999999997	0.08906232771880385
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0023739729999999997	0.08906232771880385
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0023739729999999997	0.08906232771880385
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0023739729999999997	0.08906232771880385
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0023739729999999997	0.08906232771880385
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0023739729999999997	0.08906232771880385
GRACILE BONE DYSPLASIA; GCLEB	0.0023739729999999997	0.08906232771880385
TETRASOMY 5P	0.0023739729999999997	0.08906232771880385
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0023739729999999997	0.08906232771880385
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0023739729999999997	0.08906232771880385
NEPHROGENIC DIABETES INSIPIDUS	0.0023739729999999997	0.08906232771880385
PITUITARY STALK INTERRUPTION SYNDROME	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.0023739729999999997	0.08906232771880385
ARGININOSUCCINIC ACIDURIA	0.0023739729999999997	0.08906232771880385
PROPIONIC ACIDEMIA	0.0023739729999999997	0.08906232771880385
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0023739729999999997	0.08906232771880385
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0023739729999999997	0.08906232771880385
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0023739729999999997	0.08906232771880385
HEREDITARY FOLATE MALABSORPTION	0.0023739729999999997	0.08906232771880385
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0023739729999999997	0.08906232771880385
OROFACIODIGITAL SYNDROME TYPE 6	0.0023739729999999997	0.08906232771880385
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0023739729999999997	0.08906232771880385
EAST SYNDROME	0.0023739729999999997	0.08906232771880385
INFANTILE REFSUM DISEASE	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0023739729999999997	0.08906232771880385
2P21 MICRODELETION SYNDROME	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0023739729999999997	0.08906232771880385
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0023739729999999997	0.08906232771880385
FOLATE MALABSORPTION, HEREDITARY	0.0023739729999999997	0.08906232771880385
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0023739729999999997	0.08906232771880385
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880385
FUCOSIDOSIS	0.0023739729999999997	0.08906232771880385
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880385
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0023739729999999997	0.08906232771880385
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0023739729999999997	0.08906232771880385
COWDEN SYNDROME	0.0023739729999999997	0.08906232771880385
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0023739729999999997	0.08906232771880385
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0023739729999999997	0.08906232771880385
MOSAIC TRISOMY 14	0.0023739729999999997	0.08906232771880385
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08749902973856458
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.002332303	0.08749902973856458
ANGELMAN SYNDROME	0.002332303	0.08749902973856458
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002332303	0.08749902973856458
JOUBERT SYNDROME WITH RENAL DEFECT	0.002332303	0.08749902973856458
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.002332303	0.08749902973856458
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.002332303	0.08749902973856458
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002332303	0.08749902973856458
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08749902973856458
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002332303	0.08749902973856458
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.002332303	0.08749902973856458
MUENKE SYNDROME	0.002332303	0.08749902973856458
SCHIZENCEPHALY	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.002332303	0.08749902973856458
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08749902973856458
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002332303	0.08749902973856458
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002332303	0.08749902973856458
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002332303	0.08749902973856458
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.002332303	0.08749902973856458
INCONTINENTIA PIGMENTI	0.002332303	0.08749902973856458
SOTOS SYNDROME	0.002332303	0.08749902973856458
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002332303	0.08749902973856458
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.002332303	0.08749902973856458
OCULOECTODERMAL SYNDROME; OES	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002332303	0.08749902973856458
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08749902973856458
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002332303	0.08749902973856458
OPTIC PATHWAY GLIOMA	0.002332303	0.08749902973856458
HARTNUP DISEASE	0.002332303	0.08749902973856458
SCHINDLER DISEASE, TYPE I	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08749902973856458
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002332303	0.08749902973856458
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.002332303	0.08749902973856458
GLYCEROL KINASE DEFICIENCY; GKD	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08749902973856458
WEAVER SYNDROME	0.002332303	0.08749902973856458
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08749902973856458
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002332303	0.08749902973856458
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002332303	0.08749902973856458
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.002332303	0.08749902973856458
MONOSOMY 9Q22.3	0.002332303	0.08749902973856458
XQ21 MICRODELETION SYNDROME	0.002332303	0.08749902973856458
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002332303	0.08749902973856458
RAYNAUD-CLAES SYNDROME; MRXSRC	0.002332303	0.08749902973856458
JOUBERT SYNDROME	0.002332303	0.08749902973856458
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.002332303	0.08749902973856458
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0020434299999999997	0.0766616268720981
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0020434299999999997	0.0766616268720981
JOHNSON NEUROECTODERMAL SYNDROME	0.0020434299999999997	0.0766616268720981
JOHANSON-BLIZZARD SYNDROME	0.0020434299999999997	0.0766616268720981
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0020434299999999997	0.0766616268720981
ACROOTOOCULAR SYNDROME	0.0020434299999999997	0.0766616268720981
MEIER-GORLIN SYNDROME 3; MGORS3	0.0020434299999999997	0.0766616268720981
PSEUDOPROGERIA SYNDROME	0.0020434299999999997	0.0766616268720981
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.0020434299999999997	0.0766616268720981
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0020434299999999997	0.0766616268720981
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0020434299999999997	0.0766616268720981
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0020434299999999997	0.0766616268720981
SEVERE COMBINED IMMUNODEFICIENCY	0.0020434299999999997	0.0766616268720981
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0020434299999999997	0.0766616268720981
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0020434299999999997	0.0766616268720981
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0020434299999999997	0.0766616268720981
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.0020434299999999997	0.0766616268720981
19Q13.11 MICRODELETION SYNDROME	0.0020434299999999997	0.0766616268720981
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0020434299999999997	0.0766616268720981
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0020434299999999997	0.0766616268720981
WARBURG MICRO SYNDROME 1	0.0020434299999999997	0.0766616268720981
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.0020434299999999997	0.0766616268720981
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00200176	0.07509832889185884
MASA SYNDROME	0.00200176	0.07509832889185884
HALLERMANN-STREIFF SYNDROME	0.00200176	0.07509832889185884
FANCONI ANEMIA	0.00200176	0.07509832889185884
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00200176	0.07509832889185884
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00200176	0.07509832889185884
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00200176	0.07509832889185884
LAMBOTTE SYNDROME	0.00200176	0.07509832889185884
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00200176	0.07509832889185884
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00200176	0.07509832889185884
SECKEL SYNDROME 5; SCKL5	0.00200176	0.07509832889185884
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00200176	0.07509832889185884
SCHWARTZ-JAMPEL SYNDROME	0.00200176	0.07509832889185884
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00200176	0.07509832889185884
FOCAL DERMAL HYPOPLASIA; FDH	0.00200176	0.07509832889185884
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00200176	0.07509832889185884
MUCOLIPIDOSIS TYPE IV	0.00200176	0.07509832889185884
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00200176	0.07509832889185884
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00200176	0.07509832889185884
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00200176	0.07509832889185884
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00200176	0.07509832889185884
OTOMANDIBULAR SYNDROME	0.00200176	0.07509832889185884
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.06915738388929706
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001843403	0.06915738388929706
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001843403	0.06915738388929706
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.06915738388929706
RUVALCABA SYNDROME	0.001843403	0.06915738388929706
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001843403	0.06915738388929706
17Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001843403	0.06915738388929706
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001843403	0.06915738388929706
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.06915738388929706
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001843403	0.06915738388929706
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.06915738388929706
3Q29 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.06915738388929706
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.06915738388929706
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001843403	0.06915738388929706
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.06915738388929706
RING CHROMOSOME 22 SYNDROME	0.001843403	0.06915738388929706
MICRO SYNDROME	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.06915738388929706
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001843403	0.06915738388929706
MEVALONIC ACIDURIA	0.001843403	0.06915738388929706
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001843403	0.06915738388929706
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.06915738388929706
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001843403	0.06915738388929706
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.06915738388929706
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001843403	0.06915738388929706
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001843403	0.06915738388929706
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.06915738388929706
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.06915738388929706
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.06915738388929706
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001843403	0.06915738388929706
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001843403	0.06915738388929706
CEDNIK SYNDROME	0.001843403	0.06915738388929706
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001843403	0.06915738388929706
GALACTOSEMIA	0.001843403	0.06915738388929706
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.06915738388929706
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.06915738388929706
GENITOPATELLAR SYNDROME	0.001843403	0.06915738388929706
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001843403	0.06915738388929706
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001843403	0.06915738388929706
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001843403	0.06915738388929706
COFFIN-SIRIS SYNDROME 4; CSS4	0.001843403	0.06915738388929706
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
COFFIN-SIRIS SYNDROME 3; CSS3	0.001843403	0.06915738388929706
AICARDI-GOUTIÈRES SYNDROME	0.001843403	0.06915738388929706
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.06915738388929706
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001843403	0.06915738388929706
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
MACDERMOT-WINTER SYNDROME	0.001843403	0.06915738388929706
ALG3-CDG	0.001843403	0.06915738388929706
ALG1-CDG	0.001843403	0.06915738388929706
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001843403	0.06915738388929706
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001843403	0.06915738388929706
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001843403	0.06915738388929706
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.06915738388929706
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001843403	0.06915738388929706
HSD10 DISEASE	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001843403	0.06915738388929706
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.06915738388929706
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
AICARDI-GOUTIERES SYNDROME 7	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.06915738388929706
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
CLASSIC PHENYLKETONURIA	0.001843403	0.06915738388929706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001843403	0.06915738388929706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.06915738388929706
WALKER-WARBURG SYNDROME	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001843403	0.06915738388929706
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001843403	0.06915738388929706
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001843403	0.06915738388929706
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001843403	0.06915738388929706
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001843403	0.06915738388929706
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001843403	0.06915738388929706
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.06915738388929706
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001843403	0.06915738388929706
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001843403	0.06915738388929706
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001843403	0.06915738388929706
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001843403	0.06915738388929706
FILIPPI SYNDROME	0.001843403	0.06915738388929706
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.06915738388929706
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.06915738388929706
LISSENCEPHALY 4	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.06915738388929706
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.06915738388929706
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.06915738388929706
ADAMS-OLIVER SYNDROME 1; AOS1	0.001843403	0.06915738388929706
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001843403	0.06915738388929706
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.06915738388929706
LISSENCEPHALY 8; LIS8	0.001843403	0.06915738388929706
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001843403	0.06915738388929706
DPAGT1-CDG	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.06915738388929706
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001843403	0.06915738388929706
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.06915738388929706
HEART AND BRAIN MALFORMATION SYNDROME	0.001843403	0.06915738388929706
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.001832554	0.06875037117541137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001832554	0.06875037117541137
OROFACIODIGITAL SYNDROME VI	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.001832554	0.06875037117541137
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001832554	0.06875037117541137
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001832554	0.06875037117541137
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001832554	0.06875037117541137
NIEMANN-PICK DISEASE, TYPE A	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME	0.001832554	0.06875037117541137
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001832554	0.06875037117541137
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001832554	0.06875037117541137
NAVAJO NEUROHEPATOPATHY	0.001832554	0.06875037117541137
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.001832554	0.06875037117541137
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001832554	0.06875037117541137
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001832554	0.06875037117541137
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001832554	0.06875037117541137
XIA-GIBBS SYNDROME	0.001832554	0.06875037117541137
MCKUSICK-KAUFMAN SYNDROME	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001832554	0.06875037117541137
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001832554	0.06875037117541137
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001832554	0.06875037117541137
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001832554	0.06875037117541137
OROTIC ACIDURIA	0.001832554	0.06875037117541137
JOUBERT SYNDROME 2	0.001832554	0.06875037117541137
FARBER DISEASE	0.001832554	0.06875037117541137
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.001832554	0.06875037117541137
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001832554	0.06875037117541137
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.001832554	0.06875037117541137
DE BARSY SYNDROME	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001832554	0.06875037117541137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001832554	0.06875037117541137
CHROMOSOME 16Q22 DELETION SYNDROME	0.001832554	0.06875037117541137
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.001832554	0.06875037117541137
TARP SYNDROME; TARPS	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001832554	0.06875037117541137
HYPOTONIA-CYSTINURIA SYNDROME	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 3B	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001832554	0.06875037117541137
XQ27.3Q28 DUPLICATION SYNDROME	0.001832554	0.06875037117541137
SPINOCEREBELLAR ATAXIA TYPE 7	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001832554	0.06875037117541137
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.001832554	0.06875037117541137
GALACTOSE EPIMERASE DEFICIENCY	0.001832554	0.06875037117541137
OTOPALATODIGITAL SYNDROME TYPE 2	0.001832554	0.06875037117541137
CENTRAL DIABETES INSIPIDUS	0.001828419	0.06859524189419494
GLUTARIC ACIDEMIA I; GA1	0.001828419	0.06859524189419494
KRABBE DISEASE	0.001828419	0.06859524189419494
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419494
ADDISON DISEASE	0.001828419	0.06859524189419494
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.06859524189419494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001828419	0.06859524189419494
HYPOPHOSPHATASIA, INFANTILE	0.001828419	0.06859524189419494
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.06859524189419494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001828419	0.06859524189419494
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419494
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001828419	0.06859524189419494
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.001828419	0.06859524189419494
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419494
RAMON SYNDROME	0.001828419	0.06859524189419494
HYPER-BETA-ALANINEMIA	0.001828419	0.06859524189419494
HYPERLEUCINE-ISOLEUCINEMIA	0.001828419	0.06859524189419494
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.001828419	0.06859524189419494
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001828419	0.06859524189419494
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.001828419	0.06859524189419494
GITELMAN SYNDROME	0.001828419	0.06859524189419494
MOGS-CDG	0.001828419	0.06859524189419494
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.06859524189419494
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.001828419	0.06859524189419494
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.001828419	0.06859524189419494
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001828419	0.06859524189419494
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.001828419	0.06859524189419494
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.001828419	0.06859524189419494
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001828419	0.06859524189419494
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001828419	0.06859524189419494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.001828419	0.06859524189419494
COPPER DEFICIENCY, FAMILIAL BENIGN	0.001828419	0.06859524189419494
ALEXANDER DISEASE	0.001828419	0.06859524189419494
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.001828419	0.06859524189419494
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.001828419	0.06859524189419494
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.001828419	0.06859524189419494
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001828419	0.06859524189419494
CITRULLINEMIA TYPE I	0.001828419	0.06859524189419494
ACUTE ADRENAL INSUFFICIENCY	0.001828419	0.06859524189419494
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001828419	0.06859524189419494
JOUBERT SYNDROME 21	0.001790884	0.06718707319517211
LAMB-SHAFFER SYNDROME	0.001790884	0.06718707319517211
JOUBERT SYNDROME 14	0.001790884	0.06718707319517211
CODAS SYNDROME	0.001790884	0.06718707319517211
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.06718707319517211
CHAR SYNDROME	0.001790884	0.06718707319517211
ARTERIAL TORTUOSITY SYNDROME	0.001790884	0.06718707319517211
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06718707319517211
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06718707319517211
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.06718707319517211
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.001790884	0.06718707319517211
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.06718707319517211
MEIER-GORLIN SYNDROME 7	0.001790884	0.06718707319517211
GABRIELE-DE VRIES SYNDROME; GADEVS	0.001790884	0.06718707319517211
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.06718707319517211
HYPERTRYPTOPHANEMIA; HYPTRP	0.001790884	0.06718707319517211
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.06718707319517211
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.06718707319517211
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.06718707319517211
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.06718707319517211
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06718707319517211
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001790884	0.06718707319517211
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.06718707319517211
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06718707319517211
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.06718707319517211
CHAR SYNDROME	0.001790884	0.06718707319517211
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.001790884	0.06718707319517211
3MC SYNDROME 2	0.001790884	0.06718707319517211
RAHMAN SYNDROME	0.001790884	0.06718707319517211
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06718707319517211
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.06718707319517211
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06718707319517211
16P11.2P12.2 MICRODELETION SYNDROME	0.001790884	0.06718707319517211
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.06718707319517211
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.001790884	0.06718707319517211
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.06718707319517211
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.06718707319517211
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.001790884	0.06718707319517211
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.06718707319517211
FLOATING-HARBOR SYNDROME	0.001790884	0.06718707319517211
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.06718707319517211
ISOLATED PLAGIOCEPHALY	0.001790884	0.06718707319517211
TETRASOMY X	0.001790884	0.06718707319517211
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.06718707319517211
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.06718707319517211
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001790884	0.06718707319517211
MUSCLE-EYE-BRAIN DISEASE	0.001786749	0.06703194391395567
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001786749	0.06703194391395567
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001786749	0.06703194391395567
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001786749	0.06703194391395567
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001786749	0.06703194391395567
CROUZON SYNDROME	0.001786749	0.06703194391395567
DYSEQUILIBRIUM SYNDROME	0.001786749	0.06703194391395567
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.06703194391395567
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.06703194391395567
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06703194391395567
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.06703194391395567
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.001786749	0.06703194391395567
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06703194391395567
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.001786749	0.06703194391395567
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06703194391395567
SAETHRE-CHOTZEN SYNDROME	0.001786749	0.06703194391395567
GAPO SYNDROME; GAPOS	0.001786749	0.06703194391395567
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001786749	0.06703194391395567
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06703194391395567
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001786749	0.06703194391395567
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.06703194391395567
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.06703194391395567
CHIME SYNDROME	0.001786749	0.06703194391395567
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06703194391395567
FRAGILE X SYNDROME	0.001786749	0.06703194391395567
GM1 GANGLIOSIDOSIS	0.001786749	0.06703194391395567
KNOBLOCH SYNDROME	0.001786749	0.06703194391395567
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001786749	0.06703194391395567
MENTAL RETARDATION, X-LINKED 1	0.001786749	0.06703194391395567
CONGENITAL HYDROCEPHALUS	0.001786749	0.06703194391395567
LINEAR VERRUCOUS NEVUS SYNDROME	0.001786749	0.06703194391395567
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06703194391395567
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.06703194391395567
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001786749	0.06703194391395567
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001786749	0.06703194391395567
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.04884542734590457
RAINE SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04884542734590457
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04884542734590457
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.04884542734590457
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.04884542734590457
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04884542734590457
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.04884542734590457
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.04884542734590457
LOWRY-MACLEAN SYNDROME	0.001301984	0.04884542734590457
CONGENITAL VARICELLA SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.04884542734590457
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.001301984	0.04884542734590457
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04884542734590457
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04884542734590457
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.04884542734590457
RING CHROMOSOME 12 SYNDROME	0.001301984	0.04884542734590457
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04884542734590457
OKAMOTO SYNDROME	0.001301984	0.04884542734590457
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.04884542734590457
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.04884542734590457
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.04884542734590457
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.04884542734590457
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.04884542734590457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.04884542734590457
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.04884542734590457
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04884542734590457
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.001301984	0.04884542734590457
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.04884542734590457
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.04884542734590457
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04884542734590457
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04884542734590457
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.04884542734590457
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.04884542734590457
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.04884542734590457
SAY-BARBER-MILLER SYNDROME	0.001301984	0.04884542734590457
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.04884542734590457
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.04884542734590457
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.04884542734590457
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.04884542734590457
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04884542734590457
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04884542734590457
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04884542734590457
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04884542734590457
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.04884542734590457
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.04884542734590457
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001301984	0.04884542734590457
HYPERTRICHOSIS CUBITI	0.001301984	0.04884542734590457
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04884542734590457
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.04884542734590457
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.04884542734590457
LIG4 SYNDROME	0.001301984	0.04884542734590457
MOSAIC TRISOMY 9	0.001301984	0.04884542734590457
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04884542734590457
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.04884542734590457
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.001301984	0.04884542734590457
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04884542734590457
MONOSOMY 13Q34	0.001301984	0.04884542734590457
CEREBROFACIOARTICULAR SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.04884542734590457
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001301984	0.04884542734590457
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04884542734590457
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.04884542734590457
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.04884542734590457
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04884542734590457
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04884542734590457
TRISOMY 18	0.001301984	0.04884542734590457
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.04884542734590457
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.04884542734590457
BRESEK SYNDROME	0.001301984	0.04884542734590457
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04884542734590457
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.04884542734590457
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.04884542734590457
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04884542734590457
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.04884542734590457
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04884542734590457
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04884542734590457
AICARDI-GOUTIERES SYNDROME 6	0.001301984	0.04884542734590457
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590457
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04884542734590457
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04884542734590457
ALAZAMI SYNDROME; ALAZS	0.001301984	0.04884542734590457
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.001301984	0.04884542734590457
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04884542734590457
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.04884542734590457
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04884542734590457
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.04884542734590457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.04884542734590457
WARSAW BREAKAGE SYNDROME; WABS	0.001301984	0.04884542734590457
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001301984	0.04884542734590457
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04884542734590457
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04884542734590457
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.04884542734590457
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.04884542734590457
RIDDLE SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.04869029806468812
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.04869029806468812
MENKES DISEASE	0.001297849	0.04869029806468812
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.001297849	0.04869029806468812
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001297849	0.04869029806468812
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001297849	0.04869029806468812
MICROPHTHALMIA, SYNDROMIC 1	0.001297849	0.04869029806468812
PHENYLKETONURIA	0.001297849	0.04869029806468812
OROFACIODIGITAL SYNDROME I; OFD1	0.001297849	0.04869029806468812
SANJAD-SAKATI SYNDROME	0.001297849	0.04869029806468812
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.001297849	0.04869029806468812
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.04869029806468812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.04869029806468812
KEARNS-SAYRE SYNDROME; KSS	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.04869029806468812
MICROPHTHALMIA, LENZ TYPE	0.001297849	0.04869029806468812
MENKES DISEASE	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.04869029806468812
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001297849	0.04869029806468812
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.04869029806468812
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.04869029806468812
WOLCOTT-RALLISON SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.04869029806468812
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.04869029806468812
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
FILIPPI SYNDROME; FLPIS	0.001297849	0.04869029806468812
MOYNAHAN SYNDROME	0.001297849	0.04869029806468812
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.04869029806468812
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.04869029806468812
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.001297849	0.04869029806468812
COHEN SYNDROME	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.04869029806468812
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001297849	0.04869029806468812
TRIPLE A SYNDROME	0.001297849	0.04869029806468812
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.001297849	0.04869029806468812
XYLOSIDASE DEFICIENCY	0.001297849	0.04869029806468812
ASPARTYLGLUCOSAMINURIA; AGU	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.04869029806468812
SJÖGREN-LARSSON SYNDROME	0.001297849	0.04869029806468812
CAMOS SYNDROME	0.001297849	0.04869029806468812
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.04869029806468812
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.04869029806468812
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.04869029806468812
COFFIN-LOWRY SYNDROME; CLS	0.001297849	0.04869029806468812
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
NEVUS COMEDONICUS SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, X-LINKED 102	0.001297849	0.04869029806468812
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.04869029806468812
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.04869029806468812
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.04869029806468812
DISTAL TRISOMY 15Q	0.001297849	0.04869029806468812
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.04869029806468812
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.04869029806468812
BANGSTAD SYNDROME	0.001297849	0.04869029806468812
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.04869029806468812
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.001297849	0.04869029806468812
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.04869029806468812
TETRASOMY 18P	0.001297849	0.04869029806468812
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001297849	0.04869029806468812
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001297849	0.04869029806468812
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.04869029806468812
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.001297849	0.04869029806468812
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.04869029806468812
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.04869029806468812
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.04869029806468812
TYROSINEMIA TYPE 2	0.001297849	0.04869029806468812
WORSTER-DROUGHT SYNDROME	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.04869029806468812
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.04869029806468812
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.001297849	0.04869029806468812
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001297849	0.04869029806468812
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.04869029806468812
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.04869029806468812
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.04869029806468812
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.001297849	0.04869029806468812
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.04869029806468812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.001297849	0.04869029806468812
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.04869029806468812
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.04869029806468812
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.04869029806468812
LISSENCEPHALY 3; LIS3	0.001297849	0.04869029806468812
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.001297849	0.04869029806468812
PERRAULT SYNDROME 3	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.04869029806468812
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.04869029806468812
PSEUDO-TORCH SYNDROME 2	0.001297849	0.04869029806468812
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001297849	0.04869029806468812
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080245
NOONAN SYNDROME 8; NS8	0.001287	0.04828328535080245
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080245
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080245
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080245
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.001287	0.04828328535080245
GLYCOGEN STORAGE DISEASE IV	0.001287	0.04828328535080245
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080245
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080245
OMENN SYNDROME	0.001287	0.04828328535080245
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080245
GALACTOSEMIA	0.001287	0.04828328535080245
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080245
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080245
LYSINURIC PROTEIN INTOLERANCE; LPI	0.001287	0.04828328535080245
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080245
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080245
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080245
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080245
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080245
TRICHOHEPATOENTERIC SYNDROME 2	0.001287	0.04828328535080245
PRUNE BELLY SYNDROME	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080245
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080245
MELORHEOSTOSIS	0.001287	0.04828328535080245
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.001287	0.04828328535080245
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080245
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.001287	0.04828328535080245
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080245
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080245
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.001287	0.04828328535080245
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.001287	0.04828328535080245
ATYPICAL WERNER SYNDROME	0.001287	0.04828328535080245
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.001287	0.04828328535080245
DIARRHEA 9; DIAR9	0.001287	0.04828328535080245
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.001287	0.04828328535080245
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.001287	0.04828328535080245
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080245
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080245
HYPERCALCEMIA, INFANTILE, 1	0.001287	0.04828328535080245
CUSHING DISEASE	0.001287	0.04828328535080245
KAPUR-TORIELLO SYNDROME	0.001287	0.04828328535080245
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.001287	0.04828328535080245
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080245
HYPERCALCEMIA, INFANTILE 2	0.001287	0.04828328535080245
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
SECONDARY SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
AUTOSOMAL AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080245
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.001287	0.04828328535080245
MATTHEW-WOOD SYNDROME	0.001287	0.04828328535080245
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.001287	0.04828328535080245
ACTH-INDEPENDENT CUSHING SYNDROME	0.001287	0.04828328535080245
ACTH-DEPENDENT CUSHING SYNDROME	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080245
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080245
RAVINE SYNDROME	0.001287	0.04828328535080245
CLASSIC MULTIMINICORE MYOPATHY	0.001287	0.04828328535080245
EDINBURGH MALFORMATION SYNDROME	0.001287	0.04828328535080245
CAMPOMELIC DYSPLASIA	0.001287	0.04828328535080245
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080245
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080245
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.001287	0.04828328535080245
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080245
RETICULAR DYSGENESIS	0.001287	0.04828328535080245
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080245
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.001287	0.04828328535080245
INFANTILE SYSTEMIC HYALINOSIS	0.001287	0.04828328535080245
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080245
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080245
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.001287	0.04828328535080245
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080245
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA	0.001287	0.04828328535080245
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080245
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080245
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.001287	0.04828328535080245
DOUBLE OUTLET RIGHT VENTRICLE	0.001287	0.04828328535080245
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA TYPE 1	0.001287	0.04828328535080245
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080245
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.001287	0.04828328535080245
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080245
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080245
WILSON DISEASE	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.001287	0.04828328535080245
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080245
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080245
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080245
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.001287	0.04828328535080245
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080245
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.001287	0.04828328535080245
MICROPHTHALMIA WITH LIMB ANOMALIES	0.001287	0.04828328535080245
PEARSON SYNDROME	0.001287	0.04828328535080245
HYPOTONIA-CYSTINURIA SYNDROME	0.001287	0.04828328535080245
LYSINURIC PROTEIN INTOLERANCE	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.001287	0.04828328535080245
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080245
MAJEED SYNDROME	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080245
VALINEMIA	0.001287	0.04828328535080245
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080245
CLASSIC GALACTOSEMIA	0.001287	0.04828328535080245
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080245
CRYPTOSPORIDIOSIS	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080245
BARTH SYNDROME; BTHS	0.001287	0.04828328535080245
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.001287	0.04828328535080245
601095 HARROD SYNDROME	0.001287	0.04828328535080245
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.001287	0.04828328535080245
MARSHALL-SMITH SYNDROME	0.001287	0.04828328535080245
CATEL-MANZKE SYNDROME	0.001287	0.04828328535080245
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.001287	0.04828328535080245
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.001287	0.04828328535080245
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.001287	0.04828328535080245
MYOPATHIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080245
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080245
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.001287	0.04828328535080245
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
RIGID SPINE MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.001287	0.04828328535080245
BRADDOCK SYNDROME	0.001287	0.04828328535080245
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.001287	0.04828328535080245
BARBER-SAY SYNDROME	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080245
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080245
X-LINKED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.001287	0.04828328535080245
IMMUNODEFICIENCY 9; IMD9	0.001287	0.04828328535080245
JUVENILE POLYPOSIS SYNDROME	0.001287	0.04828328535080245
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080245
PORPHYRIA, ACUTE HEPATIC	0.001287	0.04828328535080245
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.001287	0.04828328535080245
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.001287	0.04828328535080245
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080245
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080245
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.001287	0.04828328535080245
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.001287	0.04828328535080245
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080245
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080245
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	0.04671998737056319
NANCE-HORAN SYNDROME	0.00124533	0.04671998737056319
RENAL COLOBOMA SYNDROME	0.00124533	0.04671998737056319
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.04671998737056319
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
HEMIFACIAL MICROSOMIA	0.00124533	0.04671998737056319
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.04671998737056319
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.04671998737056319
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.04671998737056319
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.04671998737056319
ROBINOW-SORAUF SYNDROME	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.04671998737056319
OPTIC ATROPHY 1; OPA1	0.00124533	0.04671998737056319
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.04671998737056319
STIFF SKIN SYNDROME	0.00124533	0.04671998737056319
6P22 MICRODELETION SYNDROME	0.00124533	0.04671998737056319
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.04671998737056319
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.04671998737056319
COOPER-JABS SYNDROME	0.00124533	0.04671998737056319
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.04671998737056319
NANOPHTHALMOS	0.00124533	0.04671998737056319
WOOLLY HAIR	0.00124533	0.04671998737056319
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.04671998737056319
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.04671998737056319
HYPERTELORISM, TEEBI TYPE	0.00124533	0.04671998737056319
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.04671998737056319
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00124533	0.04671998737056319
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.04671998737056319
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00124533	0.04671998737056319
AASE-SMITH SYNDROME	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.04671998737056319
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.04671998737056319
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	0.04671998737056319
BENCZE SYNDROME	0.00124533	0.04671998737056319
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.04671998737056319
WILLIAMS-BEUREN SYNDROME; WBS	0.00124533	0.04671998737056319
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.04671998737056319
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.04671998737056319
X-LINKED RETINAL DYSPLASIA	0.00124533	0.04671998737056319
IVIC SYNDROME	0.00124533	0.04671998737056319
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.04671998737056319
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.04671998737056319
ABDUCENS PALSY	0.00124533	0.04671998737056319
X-LINKED RECESSIVE OCULAR ALBINISM	0.00124533	0.04671998737056319
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.04671998737056319
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.04671998737056319
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.04671998737056319
BASAL CELL NEVUS SYNDROME	0.00124533	0.04671998737056319
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00124533	0.04671998737056319
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.04671998737056319
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.04671998737056319
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.04671998737056319
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM	0.00124533	0.04671998737056319
15Q26 OVERGROWTH SYNDROME	0.00124533	0.04671998737056319
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.04671998737056319
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.04671998737056319
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.04671998737056319
WHITE FORELOCK WITH MALFORMATIONS	0.00124533	0.04671998737056319
SUMMITT SYNDROME	0.00124533	0.04671998737056319
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.04671998737056319
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.04671998737056319
MARSHALL SYNDROME	0.00124533	0.04671998737056319
MOEBIUS SYNDROME	0.00124533	0.04671998737056319
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.04671998737056319
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.04671998737056319
PROXIMAL SYMPHALANGISM	0.00124533	0.04671998737056319
MOSAIC TRISOMY 8	0.00124533	0.04671998737056319
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.04671998737056319
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.04671998737056319
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.04671998737056319
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.04671998737056319
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.04671998737056319
IVIC SYNDROME	0.00124533	0.04671998737056319
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.04671998737056319
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.04671998737056319
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.04671998737056319
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.04671998737056319
LAURENCE-MOON SYNDROME	0.00124533	0.04671998737056319
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.04671998737056319
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.04671998737056319
HERMANSKY-PUDLAK SYNDROME	0.00124533	0.04671998737056319
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
JACKSON-WEISS SYNDROME	0.00124533	0.04671998737056319
MORNING GLORY DISC ANOMALY	0.00124533	0.04671998737056319
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.04671998737056319
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.04671998737056319
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.04671998737056319
COATS DISEASE	0.00124533	0.04671998737056319
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.04671998737056319
GLUTATHIONURIA	0.00124533	0.04671998737056319
CROUZON DISEASE	0.00124533	0.04671998737056319
FRONTORHINY	0.00124533	0.04671998737056319
GORLIN SYNDROME	0.00124533	0.04671998737056319
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.04671998737056319
COSTELLO SYNDROME	0.00124533	0.04671998737056319
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.04671998737056319
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00124533	0.04671998737056319
FOCAL DERMAL HYPOPLASIA	0.00124533	0.04671998737056319
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	0.04671998737056319
APERT SYNDROME	0.00124533	0.04671998737056319
DOWN SYNDROME	0.00124533	0.04671998737056319
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.04671998737056319
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.04671998737056319
STICKLER SYNDROME	0.00124533	0.04671998737056319
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.04671998737056319
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.04671998737056319
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.04671998737056319
SOTOS SYNDROME 2	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.04671998737056319
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.04671998737056319
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.04671998737056319
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.04671998737056319
RETINAL CONE DYSTROPHY 3B	0.00124533	0.04671998737056319
LERI PLEONOSTEOSIS	0.00124533	0.04671998737056319
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.04671998737056319
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.04671998737056319
RETINOBLASTOMA	0.00124533	0.04671998737056319
CHANARIN-DORFMAN SYNDROME	0.00124533	0.04671998737056319
ODONTOCHONDRODYSPLASIA	0.00124533	0.04671998737056319
ANTLEY-BIXLER SYNDROME	0.00124533	0.04671998737056319
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.04671998737056319
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.04671998737056319
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.04671998737056319
CROSSED POLYSYNDACTYLY	0.00124533	0.04671998737056319
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.04671998737056319
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.04671998737056319
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.04671998737056319
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.04671998737056319
EEM SYNDROME	0.00124533	0.04671998737056319
OCULAR ALBINISM	0.00124533	0.04671998737056319
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.04671998737056319
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.04671998737056319
SENGERS SYNDROME	0.00124533	0.04671998737056319
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.04671998737056319
DUANE-RADIAL RAY SYNDROME; DRRS	0.00124533	0.04671998737056319
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.04671998737056319
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.04671998737056319
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.04671998737056319
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.04671998737056319
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00124533	0.04671998737056319
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.04671998737056319
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.04671998737056319
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.04671998737056319
STEINERT MYOTONIC DYSTROPHY	0.00124533	0.04671998737056319
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.04671998737056319
FETAL IODINE SYNDROME	0.00124533	0.04671998737056319
KEUTEL SYNDROME	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
17Q12 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
SRD5A3-CDG	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
TAY-SACHS DISEASE	0.001086973	0.040779042368001395
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
SIALIDOSIS TYPE 2	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
GRISCELLI SYNDROME	0.001086973	0.040779042368001395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.040779042368001395
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
PEHO SYNDROME; PEHO	0.001086973	0.040779042368001395
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.040779042368001395
ELEJALDE DISEASE	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040779042368001395
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
LISSENCEPHALY 1; LIS1	0.001086973	0.040779042368001395
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
DIGEORGE SYNDROME; DGS	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
SALLA DISEASE	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.040779042368001395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
SCHAAF-YANG SYNDROME; SHFYNG	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040779042368001395
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.028378341521295647
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.028378341521295647
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.028378341521295647
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.028378341521295647
VELOCARDIOFACIAL SYNDROME	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.028378341521295647
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
SECKEL SYNDROME 4	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.028378341521295647
XK APROSENCEPHALY SYNDROME	0.00075643	0.028378341521295647
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.028378341521295647
MARTSOLF SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.028378341521295647
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
WEAVER-WILLIAMS SYNDROME	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
FACIOCARDIOMELIC SYNDROME	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.028378341521295647
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
STROMME SYNDROME; STROMS	0.00075643	0.028378341521295647
CHARGE SYNDROME	0.00075643	0.028378341521295647
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.028378341521295647
MECKEL SYNDROME 12; MKS12	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
ADDUCTED THUMBS SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.028378341521295647
SECKEL SYNDROME 10; SCKL10	0.00075643	0.028378341521295647
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.028378341521295647
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.028378341521295647
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.028378341521295647
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.028378341521295647
WAGR SYNDROME	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME	0.00075643	0.028378341521295647
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.028378341521295647
ANE SYNDROME	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.028378341521295647
MONOSOMY 13Q14	0.00075643	0.028378341521295647
DISTAL MONOSOMY 13Q	0.00075643	0.028378341521295647
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.028378341521295647
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.028378341521295647
DISTAL TRISOMY 5Q	0.00075643	0.028378341521295647
MECKEL SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.028378341521295647
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.028378341521295647
RING CHROMOSOME 1 SYNDROME	0.00075643	0.028378341521295647
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.028378341521295647
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 10Q	0.00075643	0.028378341521295647
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.028378341521295647
DIABETIC EMBRYOPATHY	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.028378341521295647
FRASER SYNDROME	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.028378341521295647
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
FETAL METHYLMERCURY SYNDROME	0.00075643	0.028378341521295647
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
TRISOMY 18P	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.028378341521295647
ROBERTS SYNDROME; RBS	0.00075643	0.028378341521295647
LOWRY-WOOD SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
46,XX GONADAL DYSGENESIS	0.00075643	0.028378341521295647
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.028378341521295647
LEPRECHAUNISM	0.00075643	0.028378341521295647
15Q24 RECURRENT MICRODELETION SYNDROME	0.00075643	0.028378341521295647
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.028378341521295647
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.028378341521295647
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.028378341521295647
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.028378341521295647
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.028378341521295647
JUBERG-HAYWARD SYNDROME	0.00075643	0.028378341521295647
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.028378341521295647
SAY SYNDROME	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00075643	0.028378341521295647
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
FEINGOLD SYNDROME	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.028378341521295647
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.028378341521295647
ERMINE PHENOTYPE	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
FRIED SYNDROME	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020467085824608922
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020467085824608922
RABSON-MENDENHALL SYNDROME	0.000545554	0.020467085824608922
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608922
JOUBERT SYNDROME 15	0.000545554	0.020467085824608922
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
REVESZ SYNDROME	0.000545554	0.020467085824608922
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020467085824608922
LARSEN-LIKE SYNDROME	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608922
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 3; NS3	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 6	0.000545554	0.020467085824608922
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020467085824608922
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020467085824608922
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
SYNDROMIC DIARRHEA	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
NOONAN SYNDROME 5; NS5	0.000545554	0.020467085824608922
JOUBERT SYNDROME 7	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
NOONAN SYNDROME 6; NS6	0.000545554	0.020467085824608922
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608922
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
3C SYNDROME	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020467085824608922
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
JOUBERT SYNDROME 8	0.000545554	0.020467085824608922
MEDULLOBLASTOMA	0.000545554	0.020467085824608922
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
ARIMA SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608922
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020467085824608922
THYROID ECTOPIA	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608922
NOONAN SYNDROME 11; NS11	0.000545554	0.020467085824608922
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
TRANSALDOLASE DEFICIENCY	0.000545554	0.020467085824608922
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
ATHYREOSIS	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.020467085824608922
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.020467085824608922
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020467085824608922
THYROID HEMIAGENESIS	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
THYROID HYPOPLASIA	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020467085824608922
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608922
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020467085824608922
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020467085824608922
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608922
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608922
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020467085824608922
AURICULOCONDYLAR SYNDROME	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608922
N SYNDROME	0.000545554	0.020467085824608922
CUTIS LAXA	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020467085824608922
ZECHI-CEIDE SYNDROME	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.020467085824608922
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020467085824608922
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608922
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608922
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608922
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608922
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608922
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020467085824608922
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.020467085824608922
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
TRISOMY 12P	0.000545554	0.020467085824608922
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
TRISOMY 8Q	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020467085824608922
CHOPS SYNDROME; CHOPS	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608922
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608922
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608922
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020467085824608922
JOUBERT SYNDROME 1	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608922
PROPIONIC ACIDEMIA	0.000545554	0.020467085824608922
YUNIS-VARON SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020467085824608922
WEAVER SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 24	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020467085824608922
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020467085824608922
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020467085824608922
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
JOUBERT SYNDROME 28	0.000545554	0.020467085824608922
JOUBERT SYNDROME 25	0.000545554	0.020467085824608922
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020467085824608922
JOUBERT SYNDROME 27	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
LASSA FEVER	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020311956543392476
SCLERODERMA	0.000541419	0.020311956543392476
SIALIDOSIS TYPE 1	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020311956543392476
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
BEHÇET DISEASE	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
WHIPPLE DISEASE	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
WOLFRAM SYNDROME	0.000541419	0.020311956543392476
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
CHOREOACANTHOCYTOSIS	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
LYNCH SYNDROME	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020311956543392476
RETT SYNDROME; RTT	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
PORPHYRIA	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
KALLMANN SYNDROME	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
FAMILIAL COLORECTAL CANCER TYPE X	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
